WO2015038352A1 - Implantable medical device with a window and with means for optical communication with external devices - Google Patents

Implantable medical device with a window and with means for optical communication with external devices Download PDF

Info

Publication number
WO2015038352A1
WO2015038352A1 PCT/US2014/053264 US2014053264W WO2015038352A1 WO 2015038352 A1 WO2015038352 A1 WO 2015038352A1 US 2014053264 W US2014053264 W US 2014053264W WO 2015038352 A1 WO2015038352 A1 WO 2015038352A1
Authority
WO
WIPO (PCT)
Prior art keywords
ipg
window
case
optical
external
Prior art date
Application number
PCT/US2014/053264
Other languages
French (fr)
Inventor
Jeffery Van Funderburk
Original Assignee
Boston Scientific Neuromodulation Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boston Scientific Neuromodulation Corporation filed Critical Boston Scientific Neuromodulation Corporation
Publication of WO2015038352A1 publication Critical patent/WO2015038352A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/372Arrangements in connection with the implantation of stimulators
    • A61N1/37211Means for communicating with stimulators
    • A61N1/37217Means for communicating with stimulators characterised by the communication link, e.g. acoustic or tactile
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/372Arrangements in connection with the implantation of stimulators
    • A61N1/37211Means for communicating with stimulators
    • A61N1/37235Aspects of the external programmer
    • A61N1/37247User interfaces, e.g. input or presentation means
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/372Arrangements in connection with the implantation of stimulators
    • A61N1/375Constructional arrangements, e.g. casings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/372Arrangements in connection with the implantation of stimulators
    • A61N1/378Electrical supply
    • A61N1/3787Electrical supply from an external energy source

Definitions

  • the present invention relates to wireless communications with and wireless charging of an implantable medical device such as an implantable pulse generator.
  • Implantable stimulation devices are devices that generate and deliver electrical stimuli to nerves and tissues for the therapy of various biological disorders, such as pacemakers to treat cardiac arrhythmia, defibrillators to treat cardiac fibrillation, cochlear stimulators to treat deafness, retinal stimulators to treat blindness, muscle stimulators to produce coordinated limb movement, spinal cord stimulators to treat chronic pain, cortical and deep brain stimulators to treat motor and psychological disorders, and other neural stimulators to treat urinary incontinence, sleep apnea, shoulder subluxation, etc.
  • SCS Spinal Cord Stimulation
  • the present invention may find applicability in any implantable medical device system.
  • a SCS system typically includes an Implantable Pulse Generator (IPG) 10, which includes a biocompatible device case 12 formed of metallic material such as titanium for example.
  • the case 12 typically holds the circuitry and battery 14 (Fig. 2B) necessary for the IPG to function, although IPGs can also be powered via external RF energy and without a battery.
  • the IPG 10 is coupled to electrodes 16 via one or more electrode leads (two such leads 18 are shown), such that the electrodes 16 form an electrode array 20.
  • the electrodes 16 are carried on a flexible body 22, which also houses the individual signal wires 24 coupled to each electrode. In the illustrated embodiment, there are eight electrodes on each lead, although the number of leads and electrodes is application specific and therefore can vary.
  • the IPG 10 typically includes an electronic substrate assembly including a printed circuit board (PCB) 30 containing various electronic components 32 necessary for operation of the IPG 10, some of which are described subsequently.
  • a telemetry coil 34 used to transmit/receive data to/from an external controller 50 (Fig. 2A); and a charging coil 36 for charging or recharging the IPG's battery 14 using an external charger 70 (Fig. 4A).
  • These coils 34 and 36 are also shown in the perspective view of the IPG 10 in Figure IB, which omits the case 12 for easier viewing.
  • the telemetry coil 34 can alternatively be fixed in header 28. Coils 34 and 36 may alternative be combined into a single telemetry/charging coil.
  • Figure 2A shows plan views of the external controller 50
  • Figure 2B shows it in cross section and in relation to the IPG 10 during a communication session.
  • the external controller 50 such as a hand-held portable programmer or a clinician's programmer, is used to set or adjust the therapy settings the IPG 10 will provide to the patient (such as which electrodes 16 are active, whether such electrodes sink and source current, and the duration, frequency, and amplitude of pulses formed at the electrodes, etc.).
  • the external controller 50 can also act as a receiver of data from the IPG 10, such as various data reporting on the IPG's status, the level of the IPG 10's battery 14, and other parameters measured or logged at the IPG 10. Such communications can occur bi-directionally via link 75.
  • the external controller 50 contains a PCB 51 on which electronic components 52 are placed to control operation of the external controller 50.
  • the external controller 50 is powered by a battery 53, but could also be powered by plugging it into a wall outlet for example.
  • a telemetry coil 54 is also present in the external controller 50, which will be discussed further below.
  • a case 59 typically made of plastic, houses the internal components of the external controller 50.
  • the external controller 50 typically comprises a user interface 55 similar to that used for a portable computer, cell phone, or other hand held electronic device, including touchable buttons 56 and a display 57.
  • a port 58 allows the external controller to be electrically coupled to a power source, to other computer devices, etc.
  • Wireless data transfer between the external controller 50 and the IPG 10 via link 75 takes place via magnetic inductive coupling between coils 54 and 34, either of which can act as the transmitter or the receiver to enable two-way communication between the two devices.
  • control circuitry 60 e.g., a microcontroller
  • Modulator 61 energizes coil 54 with an alternating current (AC) whose frequency is modulated in accordance with the state of the data bit currently being transferred in accordance with a Frequency Shift Keying (FSK) protocol.
  • AC alternating current
  • FSK Frequency Shift Keying
  • the frequency-modulated current through the coil 54 in turn generates a frequency-modulated magnetic field comprising link 75, which in turn induces a frequency-modulated current in the IPG's telemetry coil 34.
  • This received signal is demodulated 43 back into the series of digital data bits, and sent to control circuitry 38 (e.g., a microcontroller) in the IPG 10 for interpretation.
  • control circuitry 38 e.g., a microcontroller
  • Data telemetry in the opposite direction from IPG 10 to external controller 50 occurs similarly via modulator 41 and demodulator 62.
  • Inductive coupling via link 75 occurs transcutaneous ly, i.e., through the patient's tissue 100.
  • link 75 Other means for electro-magnetically communicating between the external controller 50 and IPG 10 via link 75 are known as well, including RF communications such as Bluetooth, Zigbee, etc., that are enabled patch, wire, or slot antennas.
  • link 75 would comprise a longer-range electromagnetic field, rather than the near-field magnetic field enabled by coils 54 and 34.
  • FIG 4A shows a plan view of the external charger 70
  • Figure 4B shows it in cross section and in relation to the IPG 10 during a charging session.
  • the external charger 70 is used to wirelessly charge (or recharge) the IPG's battery 14, and includes at least one PCB 72 (two are shown; see U.S. Patent Application Publication 2008/0027500); electronic components 74, some of which are subsequently discussed; a charging coil 76; and a battery 78 for providing operational power for the external charger 70 and for the production of a magnetic charging field 80 from the coil 76.
  • These components are typically housed within a case 77, which may be made of plastic for example.
  • the external charger 70 has a user interface 82, which typically comprises an on/off switch 84 to activate the production of the magnetic charging field 80; an LED 86 to indicate the status of the on/off switch 84; and a speaker 88.
  • the speaker 88 emits a "beep" for example if the external charger 70 detects that its charging coil 76 is not in good alignment with the charging coil 36 in the IPG 10 during a charging session, as discussed further below.
  • the external charger 70 is sized to be hand held and portable, and may be placed in a pouch around a patient's waist to position the external charger 70 in alignment with the IPG 10 during a charging session. Typically, the external charger 70 is touching the patient's tissue 100 during a charging session as shown, although the patient's clothing or the material of the pouch may intervene.
  • Wireless power transfer from the external charger 70 to the IPG 10 occurs by magnetic inductive coupling between coils 76 and 36.
  • a charging circuit 94 under control of control circuitry 92 (e.g., a microcontroller) energizes coil 76 with a non-data- modulated AC current (Icharge) to create the magnetic charging field 80.
  • the frequency of the magnetic charging field may be on the order of 80 kHz for example, and may be set by the inductance of the coil 76 and the capacitance of a tuning capacitor (not shown).
  • the magnetic charging field 80 induces a current in the IPG 10's charging coil 36, which current is rectified 44 to DC levels and used to provide a charging current (Ibat) to recharge the IPG's battery 14, perhaps under the control of charging and battery protection circuitry 46 as shown. This again occurs transcutaneously.
  • the IPG 10 can also communicate data back to the external charger 70 using Load Shift Keying (LSK) telemetry.
  • Relevant data such as the capacity of the battery, is sent from control circuitry 38 in the IPG 10 to a LSK modulator 40, which creates a series of digital data bits (LSK data 48).
  • This data is input to the gate of a load transistor 42 to modulate the impedance of the charging coil 36 in the IPG 10.
  • Such modulation of the charging coil 36 is detectable at the external charger 70 due to the mutual inductance between the coils 76 and 36, and will change the magnitude of the AC voltage needed at coil 76 (Vcoil) to drive the charging current, Icharge.
  • LSK demodulator 96 in the external charger 70 can detect these changes in Vcoil (AV) to recover the series of digital data bits, which data is then received at control circuitry 92 so that appropriate action can be taken, such as ceasing production of the magnetic charging field 80 (i.e., setting Icharge to zero) because the battery 14 in the IPG 10 is full.
  • AV Vcoil
  • the inventor is concerned about certain problems with traditional means of wireless communications between an external controller 50 and the IPG 10, and with traditional means of charging an IPG 10 using an external charger 70.
  • the inventor's concerns regarding communications are discussed first.
  • wireless communications to and from the IPG 10 can be attenuated by the conductive material of the case 12 as well as other conductive structures present in the IPG 10 and the external controller 50.
  • the generated AC magnetic fields will create eddy currents in such conductive structures, which essentially act as an unwanted sink for the energy in the field, thus reducing the distance at which communications and charging can reliably occur. See, e.g., USP 8,457,756.
  • Previous IPGs 10 have used non-conductive ceramic materials for the case 12, see, e.g., USP 7,351,921, which would reduce attenuation of wireless communications in IPGs using internal coils.
  • ceramic materials are also brittle and difficult to work with. Ceramic case components further require brazing to mechanically couple them together or to other metallic components, which can be difficult to perform.
  • USP 5,556,421 discloses a pacemaker which has photoemitter such as a Light Emitting Diode (LED), and a photodetector such as a phototransistor, for respectively transmitting data to and receiving data from a device external to the patient. See Fig. 15 of the '421 patent.
  • the photoemitter and photodetector are contained within the header of the pacemaker, similar to the header 28 for the IPG 10 described earlier (Fig. 1A).
  • the header is described in the '421 patent as suitably translucent to the wavelengths of optical radiation at which the LED and photodiode operate (within the range of 640 to 940 nm).
  • the three-dimensional shape of the header makes optical transmission and reception difficult, as optical radiation will reflect at the outer surfaces of the header and other reflective components in the header, such as the lead connectors 26 (see, e.g., Fig. 1A).
  • Optical radiation will also refract, attenuate, and disperse in the header material.
  • Providing optical elements in the header provides further concerns that additional feedthrough pins between the header and the interior of the case would be necessary, complicating IPG design and potentially impacting reliability.
  • USP 6,243,608 also discloses a pacemaker that can communicate optically with an external device, although once again in this reference, the optical element is contained in the header, thus suffering from the same problems discussed above with reference to the '421 patent.
  • this pacemaker has only a photoemitter and thus can only communicate optically with the external device in one direction; communication from the external device to the pacemaker occurs via magnetic induction between two coils).
  • the photoemitter can be located in an electronics module inside the pacemaker case. But in this instance, the photoemitter transmits light from inside the case to the translucent header. This too is not practical.
  • Figure 7A shows an improved IPG 110 having an optical window assembly 112 on a top flat side of its case 12 that will face outwardly of the patient when implanted.
  • Underlying and generally centered with the window assembly 1 12 are optical devices, namely a photoemitter 114 and a photodetector 116, as seen in Figure 7B (with the case 12 removed).
  • the photoemitter 1 14 and a photodetector 116 are electrically coupled to the PCB 30 of the IPG 1 10.
  • the manner in which the window assembly 172 is affixed to a hole in the case 77 is less critical, and can occur in any manner suitable for an external device.
  • the photoemitter 174 and photodetector 176 can be positioned through or on the bottom of case 77, as discussed with respect to the external controller 150 of Figure 9, although these modifications are not again depicted for simplicity.
  • the window assembly 172 could comprise a lens to better focus emitted and received radiation, and may be comprised of any material able to pass suitable amounts of optical radiation.
  • the photoemitter 174 and photodetector 176 in the external charger 170 may operate at the same wavelengths described earlier for the photoemitter 114 and a photodetector 116 in the IPG 1 10.
  • Photoemitter 174 like photoemitter 114, will illuminate tissue 101 at a sufficient depth (x) to reach the optical window assembly 1 12 of the IPG 110.
  • at least some amount of the optical radiation from photoemitter 174 in the external charger 170 will reach the photodetector 116 in the IPG 110, and at least some amount of the optical radiation from photoemitter 114 in the IPG 1 10 will reach the photodetector 176 in the external charger 170.
  • the external charger 170 can also optically communicate data to the IPG 110 along link 101a.
  • the external charger 170 when positioned over the IPG 110 can optically send an instruction to the IPG 1 10 to report its battery capacity, Vbat, along link 101b, which may be beneficial if pulses 102 are not used to indicate Vbat, or if pulses 102 are merely of constant intensity and do not contain data such as Vbat.
  • Vbat battery capacity
  • the external charger 170 can initiate a charging session by generating a magnetic charging field 80 if necessary (i.e., if Vbat is low).
  • the external charger 170 may optically send further instructions to the IPG 110 via link 101a informing the IPG 1 10 of the desired to begin charging, with such charging commencing only after the external charger 170 optically receives an acknowledgement from the IPG 1 10 via link 101b.
  • Link 101a can also be used during a charging session.
  • the external charger 170 might periodically provide information to the IPG 110 during the charging session, such as an estimation of how much longer the external charger 170 believes charging may last.
  • the external charger 170 may not have a photoemitter 174, and thus may only allow for one-way optical communications from the IPG 1 10 (via link 101b).
  • Pulses 103 may be the same as pulses 102 (Fig. 8A), which may simply continue after receipt of the magnetic charging field 80, and which may now contain additional data relevant to the charging session. Pulses 103 may include for example the IPG's battery voltage (Vbat), the temperature of the IPG (T), information indicative of the electrical coupling between the external charger 170 and the IPG 110 such as the battery charging current (Ibat), or all of these or still other parameters relevant to the current charging session. Again, although pulses 103 are shown as periodic, they don't have to be, so long as they are sent with a suitable frequency to allow the external charger 170 to optically receive data on a reasonable time scale during the charging session (e.g., every second).
  • the external charger 170 may use such optically -received data to control the magnetic charging field 80 it is producing. For example, if the external charger 170 understands that the optically-reported temperature data (T) from the IPG 1 10 is above a threshold for example, it can reduce the energy of the magnetic charging field 80, for example by lowering Icharge, or by reducing the duty cycle of the field. See, e.g., U.S. Patent Application Publication 201 1/0087307.
  • alignment detector which in the example shown comprises an intensity module 190 programmed in the external charger 170's control circuitry 92.
  • alignment is determined by assessing the received intensity (la) of optical signals transmitted by the photoemitter 1 14 in the IPG 110, and detected at the photodetector 176 in the external charger 170 via optical link 101b.
  • Optical receiver 186 in the external charger 170 can be configured to provide the received intensity, la, as describer earlier in conjunction with the external controller 150.
  • the photoemitter 1 14 in the IPG 110 issues optical pulses 104 during a charging session of a known intensity, I.
  • the pulses 102 pass through the illuminated tissue 101 (101b), they will attenuate, and thus will be received at the external charger 170 with a lower intensity, la.
  • This intensity la can be determined at the optical receiver 186 in the external charger 170 as explained earlier.
  • the window assembly 172 of the external charger will cover a broader area of the tissue 101 illuminated by the photoemitter 1 14 in the IPG 1 10, and thus the photodetector 176 in the external charger 170 will receive a larger amount of optical radiation (i.e., Ia > Ith), and thus la will be relatively high.
  • the window assembly axes and the charging coils are not collinear; the window assembly 172 covers a smaller area of the illuminated tissue 101 ; photodetector 176 receives a smaller amount of optical radiation; and Ia is relatively low (e.g., Ia ⁇ Ith), indicating poor alignment and coupling. Should the intensity module 190 detect this condition, it can notify the patient of the misalignment condition using speaker 88 as described earlier so that the patient can readjust the position of the external charger 170.
  • An IPG can be implanted at different depths (x; Fig. 8A) in different patients, and so the received intensity Ia may vary from patient to patient.
  • the intensity threshold, It is preferably established for a given patient during a training or learning phase.
  • a patient may be instructed to very carefully align the two window assemblies 172 and 112, to press the external charger 170 firmly against her tissue 100, and to turn on the external charger 170 to start generating a magnetic charging field 80.
  • the external charger 170 can then assess the strength of Ia for this known good alignment condition, and then set Ith in the intensity module 190 at an appropriate lower value.
  • Figures 15A-15D illustrate a different embodiment of an external charger 170' that as well as determining alignment optically can also determine a direction in which the external charger 170' is misaligned with respect to the IPG 1 10, and indicate this to the patient to assist in adjustment.
  • the bottom side of the external charger 170' includes a larger window assembly 172, and mounted to the PCB 72 are a number of photodetectors 176 x arranged radially around a central photoemitter 168, and also arranged radially with respect to the charging coil 76 (Fig. 7).
  • Figure 15B shows the photodetectors 176 x at the same locations, but with each having its own window assembly 172 x in the external charger's case 77.
  • a central photodetector could also be present at the central location of the photoemitter 174 to assist in communications or alignment as described earlier, but this is not shown.
  • optical receivers 186 x corresponding to the photodetectors 176 x in the external charger 170' report these intensity values Ia x to the control circuitry 92. Although separate optical receivers 186 x are shown, a single optical receiver 186 could also be used to sample the received intensities Ia x from the various photodetectors 176 x at different points in time.
  • the position determination module 194 can control the direction indicators 196 x in accordance with the receive intensities values Ia x , and may do so in manners other than by controlling their brightness, such as by pulse rate or color. If alignment pulses 104 are provided frequently enough to the external charger 170', control of the LEDs 196 by the position determination module 194 can occur in essentially real time to allow a patient to visually assess their progress toward achieving better alignment as she moves the external charger 170' by viewing the LEDs.
  • the disclosed optical techniques for determining and indicating external charger / IPG alignment do not depend on electrical measurements taken during production of a magnetic field 80, the techniques may be used prior to a charging sessions, i.e., prior to use of the external charger 170 to produce a magnetic charging field 80. This is beneficial, as it allows a patient to set the positioning of the external charger 170 before the charging session begins, which hopefully the patient would not need to revisit later during the charging session. However, should alignment change during the charging session, the disclosed techniques can still notify the user and to suggest corrections, as explained above.
  • optical alignment techniques described above with respect to the external charger 170 (Fig. 14A-15D) can also be used with the external controllers 150 and 150'. This may be beneficial to ensure good optical coupling, and hence reduced optical attenuation, between the two before or during the communicating data.
  • the disclosed optical alignment techniques may also be used in conjunction with the prior art alignment techniques described earlier.
  • the prior art techniques can be used to enable coarse alignment between the external device and the IPG 110, with the disclosed optical techniques then used for fine alignment assessment and adjustment.
  • FIG 16 shows another embodiment of an external charger 170" system that can optically communicate with IPG 1 10.
  • optical components have been moved out of the external charger 170 (Fig. 12), and into a charging head 250, including the photoemitter 174, the photodetector 176, and if necessary, optical transmitter and receiver circuitry 184 and 186.
  • the charging head also includes the charging coil 76.
  • These components may be integrated on a PCB 256, and contained within a housing 258, which may be significantly smaller and less complicated that the housing 77 used by the external charger 170.
  • the charging head 250 includes a window assembly 172, similar to that described earlier for external charger 170 but could include the other optical device placement options discussed in Figure 9.
  • the charging head 250 includes a cable 252 and a connector 254 that can couple to appropriate ports 58 or 208 on the relevant external device, which can provide a graphical user interface providing functionality similar to the user interface 82 of the external charger 70 (Fig. 4A), as described previously.
  • Power for the charging head 250, as well as to generate the magnetic charging field 80 from the charging coil 76, can come from the external device via cable 252.
  • the external charger 170" can otherwise operate similarly with the external chargers 170 and 170' described earlier to optically communicate relevant charging information, and to allow the external device to determine charging head 250 / IPG 1 10 alignment using such optical communications.
  • the graphical user interfaces of the external device are further useful in that they can provide indications of misalignment (either using their speakers, or by displaying information on their graphical user interfaces). If the charging head 250 has multiple photodetectors 176 x allowing for misalignment direction assessment (see Figs. 15A-15D), the direction indications concerning how to move the charging head 250 for better alignment can be displayed on the graphical user interfaces of these devices, essentially taking the place of LEDs 196 x in Figure 15D.
  • IPG 1 10 and external chargers 170, 170' and 170" provided reliable means for optically communicating through the patient's tissue 100, and the same benefits discussed earlier for external controller / IPG communications apply here as well.
  • Optical communications between the IPG 110 and the external controller may render certain aspects of the prior art IPG 10 and external controller 50 unnecessary.
  • FSK modulation and demodulation circuitry (Fig. 3, 41, 43, 61 and 62) as well as telemetry coils 34 and 54 are not necessary, and these coils are thus shown in dotted lines in IPG 1 10 and the various external controllers in recognition of this fact.
  • This is significant, as coils 34 and 54 take up room in their respective, which may now be made smaller when optical communications are employed.
  • Eliminating the telemetry coil 34 from the IPG 110 is particularly beneficial, as space is at a premium in an implantable devices, and because it is always desirable to make such implantable devices smaller to minimize inconvenience to the patient.
  • FSK communications still could be used between IPG 1 10 and an external controller in addition to the optical communications disclosed herein.
  • optical communications will not be subject to or provide electromagnetic interference. This can simplify circuit design in the disclosed IPG and external controllers, as coupling between such circuitry and the coils 34 or 54 is a non-issue.
  • Optical communications between the IPG 110 and the external charger may also render certain aspects of the prior art IPG 10 and external charger 70 unnecessary.
  • LSK communications from the IPG 1 10 to the external charger may not be necessary, and hence relevant LSK circuitry in both devices are shown in dotted lines (Fig. 14A). That being said, LSK communications still could be used between IPG 1 10 and an external charger in addition to the optical communications disclosed herein.
  • FIG. 17 shows an integrated external controller / charger 300 in the form of a modified external controller 150 (see Fig. 9).
  • coil 54 previously used for FSK telemetry
  • a charging coil 302 used to provide the magnetic charging field 80 to charge the IPG's battery.
  • the window assembly 304 and underlying photoemitter 164 and photodetector 166 have been moved to be generally centered with respect to the coil 302.
  • the external controller / charger 300 is integrated in a unitary housing, i.e., case 59.
  • the external device 300 can operate in an IPG communications mode having functionality similar to the external charger to set or adjust the therapy settings the IPG 1 10 provides to the patient, and to receive relevant data from the IPG 1 10.
  • the external device 300 can also operate in a charging mode to produce the magnetic charging field. These modes can operate and use optical communications to beneficial ends as discussed previously. Note that redundancies in the external controller and the external charger can be eliminated in the integrated external device 300.
  • the external device 300 may have only one optical transmitter (e.g., 144; Fig. 10) coupled to photoemitter 164, and one optical receiver (e.g., 146, Fig. 10) coupled to one photodetector 166, which would handle optical communications for all modes of operation.
  • External device 300 may also have additional photodetectors to allow for alignment direction determinations (Figs. 15A-15D), and may position the optical devices differently with respect to the case 59 (Fig. 9).
  • Figure 18 shows a modified external device 300' having integrated communication and charging capability, which uses a combined communication / charging head 350.
  • the head 350 is coupled by a cable 352 to a mobile controller.
  • the head 350 is essentially similar to the charging head 250 described earlier and can be modified as explained earlier (additional photodetectors, different placement of the optical devices, etc.), although optical communications related to external controller functionality are also passed between the head 350 and the IPG 110 in addition to optical communications used for charging.
  • the external device 300' can operate as external device 300, providing both communication and charging functionality, with the additional convenience of separating the graphical user interface from aspects of the system that need to be proximate to the IPG 1 10.
  • optical radiation used in optical communications need not have a fixed wavelength, but can comprise radiation with a wider frequency spectrum.
  • Optical communications used in different directions can occur at different wavelengths, which may facilitate full duplex communications on these links.
  • More than one set of photoemitters and corresponding photodetectors may be used to respectively transmit and receive optical radiation in a given direction along a communication link, which may operate at different wavelengths.
  • the circuitry disclosed herein can also be modified in any number of ways. For example, instead of programming modules in the various control circuitries of the devices, such modules can exists as discrete circuits outside of their control circuitries.
  • window assemblies 1 12 can be used as well.
  • the IPG 110 could contain two window assemblies 1 12 on its top side, one of which contains a photoemitter 114 and the other which contains a photodetector 116.
  • the external controller or charger could likewise contain two window assemblies, one of which contains a photoemitter and the other which contains a photodetector. This would allow different optical links to be supported in different directions (101a and 101b) through different sets of windows.
  • Another window assembly placed elsewhere on the IPG may also be useful to allow the IPG 1 10 to optically communicate with other implanted devices, such as another IPG 110.
  • window assembly 1 12 on the side of the IPG 1 10's case 12 is preferred, but not necessary in all manners in which optical communications are useful. For example, if optical communications are used to provide visual feedback regarding IPG operations, conditions, or codes to a manufacturer, clinician, or patient as described earlier, positioning of the photoemitter 1 14 that provides such indications is less critical. If used for such purposes, the photoemitter 114 could be placed elsewhere, such as in the header 28 (Fig. 1A), and electrically coupled to the circuitry inside the case via additional feedthrough wires between the case 12 and the header 28.
  • the photoemitter 1 14 could be placed inside the case, with radiation optically ported through the feedthrough, using a lens, a fiber optical cable, a window, or other structure.
  • a special optical feedthrough different from that used for the electrodes wires could also be provided. Suitable visual indications can be provided even if the optical radiation in these scenarios will travel through more complicated or optically bulky structures.
  • the implanting clinician can then attempt to re-secure the leads until a "go" signal is visually indicated, at which point the clinician could then safely implant the IPG.
  • the "no-go" signal might indicate a particular electrode that is not being measured with a suitable impedance.
  • Providing optical communication functionality to the external devices may also be beneficial as an easier way to communicate with or test such devices, or to allow them to optical communicate with each other or with other external devices.

Abstract

An improved medical device system is disclosed in which system devices are configured to communicate optically. An implantable medical device (IMD) (110) is disclosed having a hermetic window assembly (112) on one side of its case (12), through which a photoemitter (114) and photodetector (116) can transmit and receive optical signals. The optical radiation is preferably visible, which permits communications from the IMD to be seen prior to implantation and even after implantation through a patient's tissue. External controllers for adjusting therapeutic operation of the IMD, external chargers for providing a magnetic charging field to charge a battery in the IMD and combined external controllers / chargers are also disclosed that are configured to optically communicate with the IMD through the patient's tissue. The optical communication capabilities of the external charger are particularly useful in determining misalignment with the IMD.

Description

IMPLANTABLE MEDICAL DEVICE WITH A WINDOW AND WITH MEANS FOR OPTICAL COMMUNICATION WITH EXTERNAL DEVICES
CROSS REFERENCE TO RELATED APPLICATIONS
[0001] This application is related to U.S. Provisional Patent Application Serial No. 61/877,877, filed September 13, 2013, entitled "Optical Communications Between an Implantable Medical Device and External Charger."
FIELD OF THE INVENTION
[0002] The present invention relates to wireless communications with and wireless charging of an implantable medical device such as an implantable pulse generator.
BACKGROUND
[0003] Implantable stimulation devices are devices that generate and deliver electrical stimuli to nerves and tissues for the therapy of various biological disorders, such as pacemakers to treat cardiac arrhythmia, defibrillators to treat cardiac fibrillation, cochlear stimulators to treat deafness, retinal stimulators to treat blindness, muscle stimulators to produce coordinated limb movement, spinal cord stimulators to treat chronic pain, cortical and deep brain stimulators to treat motor and psychological disorders, and other neural stimulators to treat urinary incontinence, sleep apnea, shoulder subluxation, etc. The description that follows will generally focus on the use of the invention within a Spinal Cord Stimulation (SCS) system, such as that disclosed in U.S. Patent 6,516,227. However, the present invention may find applicability in any implantable medical device system.
[0004] As shown in Figures 1A and IB, a SCS system typically includes an Implantable Pulse Generator (IPG) 10, which includes a biocompatible device case 12 formed of metallic material such as titanium for example. The case 12 typically holds the circuitry and battery 14 (Fig. 2B) necessary for the IPG to function, although IPGs can also be powered via external RF energy and without a battery. The IPG 10 is coupled to electrodes 16 via one or more electrode leads (two such leads 18 are shown), such that the electrodes 16 form an electrode array 20. The electrodes 16 are carried on a flexible body 22, which also houses the individual signal wires 24 coupled to each electrode. In the illustrated embodiment, there are eight electrodes on each lead, although the number of leads and electrodes is application specific and therefore can vary. The leads 18 couple to the IPG 10 using lead connectors 26, which are fixed in a header 28 comprising epoxy for example, which header is affixed to the case 12. In a SCS application, distal ends of electrode leads 18 are typically implanted on the right and left side of the dura within the patient's spinal cord. The proximal ends of leads 18 are then tunneled through the patient's tissue 100 to a distant location such as the buttocks where the IPG 10 is implanted, where the proximal leads ends are then connected to the lead connectors 26.
[0005] As shown in cross section in Figure 2B, the IPG 10 typically includes an electronic substrate assembly including a printed circuit board (PCB) 30 containing various electronic components 32 necessary for operation of the IPG 10, some of which are described subsequently. Two coils are generally present in the IPG 10: a telemetry coil 34 used to transmit/receive data to/from an external controller 50 (Fig. 2A); and a charging coil 36 for charging or recharging the IPG's battery 14 using an external charger 70 (Fig. 4A). These coils 34 and 36 are also shown in the perspective view of the IPG 10 in Figure IB, which omits the case 12 for easier viewing. Although shown as inside in the case 12 in the Figures, the telemetry coil 34 can alternatively be fixed in header 28. Coils 34 and 36 may alternative be combined into a single telemetry/charging coil.
[0006] Figure 2A shows plan views of the external controller 50, and Figure 2B shows it in cross section and in relation to the IPG 10 during a communication session. The external controller 50, such as a hand-held portable programmer or a clinician's programmer, is used to set or adjust the therapy settings the IPG 10 will provide to the patient (such as which electrodes 16 are active, whether such electrodes sink and source current, and the duration, frequency, and amplitude of pulses formed at the electrodes, etc.). The external controller 50 can also act as a receiver of data from the IPG 10, such as various data reporting on the IPG's status, the level of the IPG 10's battery 14, and other parameters measured or logged at the IPG 10. Such communications can occur bi-directionally via link 75.
[0007] As shown in Figure 2B, the external controller 50 contains a PCB 51 on which electronic components 52 are placed to control operation of the external controller 50. The external controller 50 is powered by a battery 53, but could also be powered by plugging it into a wall outlet for example. A telemetry coil 54 is also present in the external controller 50, which will be discussed further below. A case 59, typically made of plastic, houses the internal components of the external controller 50. The external controller 50 typically comprises a user interface 55 similar to that used for a portable computer, cell phone, or other hand held electronic device, including touchable buttons 56 and a display 57. A port 58 allows the external controller to be electrically coupled to a power source, to other computer devices, etc.
[0008] Wireless data transfer between the external controller 50 and the IPG 10 via link 75 takes place via magnetic inductive coupling between coils 54 and 34, either of which can act as the transmitter or the receiver to enable two-way communication between the two devices. Referring to Figure 3, which depicts circuitry in these devices, when a series of digital data bits (FSK data 47) is to be sent from the external controller 50 to the IPG 10, control circuitry 60 (e.g., a microcontroller) provides these bits in sequence to a modulator 61. Modulator 61 energizes coil 54 with an alternating current (AC) whose frequency is modulated in accordance with the state of the data bit currently being transferred in accordance with a Frequency Shift Keying (FSK) protocol. For example, the coil 54 may nominally be tuned to resonate at 125 kHz in accordance with the inductance of the coil 54 and a tuning capacitor (not shown), which data states '0' and T altering this center frequency to fo=121 kHz and fi=129 kHz respectively. The frequency-modulated current through the coil 54 in turn generates a frequency-modulated magnetic field comprising link 75, which in turn induces a frequency-modulated current in the IPG's telemetry coil 34. This received signal is demodulated 43 back into the series of digital data bits, and sent to control circuitry 38 (e.g., a microcontroller) in the IPG 10 for interpretation. Data telemetry in the opposite direction from IPG 10 to external controller 50 occurs similarly via modulator 41 and demodulator 62. Inductive coupling via link 75 occurs transcutaneous ly, i.e., through the patient's tissue 100.
[0009] Other means for electro-magnetically communicating between the external controller 50 and IPG 10 via link 75 are known as well, including RF communications such as Bluetooth, Zigbee, etc., that are enabled patch, wire, or slot antennas. In this instance, link 75 would comprise a longer-range electromagnetic field, rather than the near-field magnetic field enabled by coils 54 and 34.
[0010] Figure 4A shows a plan view of the external charger 70, and Figure 4B shows it in cross section and in relation to the IPG 10 during a charging session. The external charger 70 is used to wirelessly charge (or recharge) the IPG's battery 14, and includes at least one PCB 72 (two are shown; see U.S. Patent Application Publication 2008/0027500); electronic components 74, some of which are subsequently discussed; a charging coil 76; and a battery 78 for providing operational power for the external charger 70 and for the production of a magnetic charging field 80 from the coil 76. These components are typically housed within a case 77, which may be made of plastic for example. [0011] The external charger 70 has a user interface 82, which typically comprises an on/off switch 84 to activate the production of the magnetic charging field 80; an LED 86 to indicate the status of the on/off switch 84; and a speaker 88. The speaker 88 emits a "beep" for example if the external charger 70 detects that its charging coil 76 is not in good alignment with the charging coil 36 in the IPG 10 during a charging session, as discussed further below. The external charger 70 is sized to be hand held and portable, and may be placed in a pouch around a patient's waist to position the external charger 70 in alignment with the IPG 10 during a charging session. Typically, the external charger 70 is touching the patient's tissue 100 during a charging session as shown, although the patient's clothing or the material of the pouch may intervene.
[0012] Wireless power transfer from the external charger 70 to the IPG 10 occurs by magnetic inductive coupling between coils 76 and 36. Referring to Figure 5, when the external charger 70 is activated (e.g., on/off switch 84 is pressed), a charging circuit 94 under control of control circuitry 92 (e.g., a microcontroller) energizes coil 76 with a non-data- modulated AC current (Icharge) to create the magnetic charging field 80. The frequency of the magnetic charging field may be on the order of 80 kHz for example, and may be set by the inductance of the coil 76 and the capacitance of a tuning capacitor (not shown). The magnetic charging field 80 induces a current in the IPG 10's charging coil 36, which current is rectified 44 to DC levels and used to provide a charging current (Ibat) to recharge the IPG's battery 14, perhaps under the control of charging and battery protection circuitry 46 as shown. This again occurs transcutaneously.
[0013] The IPG 10 can also communicate data back to the external charger 70 using Load Shift Keying (LSK) telemetry. Relevant data, such as the capacity of the battery, is sent from control circuitry 38 in the IPG 10 to a LSK modulator 40, which creates a series of digital data bits (LSK data 48). This data is input to the gate of a load transistor 42 to modulate the impedance of the charging coil 36 in the IPG 10. Such modulation of the charging coil 36 is detectable at the external charger 70 due to the mutual inductance between the coils 76 and 36, and will change the magnitude of the AC voltage needed at coil 76 (Vcoil) to drive the charging current, Icharge. If coil 36 is shorted (LSK data=l), Vcoil increases (Vcoili) to maintain Icharge; if not shorted (LSK data=0), Vcoil decreases (Vcoilo), as shown in the waveform in Figure 5. LSK demodulator 96 in the external charger 70 can detect these changes in Vcoil (AV) to recover the series of digital data bits, which data is then received at control circuitry 92 so that appropriate action can be taken, such as ceasing production of the magnetic charging field 80 (i.e., setting Icharge to zero) because the battery 14 in the IPG 10 is full. Note that the nature of LSK telemetry as described here only allows for telemetry from the IPG 10 to the external charger 70 when a magnetic charging field 80 is being produced. See, e.g., U.S. Patent Application Publication 2013/0123881 for further details regarding the use of LSK telemetry in an external charger system.
[0014] The inventor is concerned about certain problems with traditional means of wireless communications between an external controller 50 and the IPG 10, and with traditional means of charging an IPG 10 using an external charger 70. The inventor's concerns regarding communications are discussed first.
[0015] As is known, wireless communications to and from the IPG 10 can be attenuated by the conductive material of the case 12 as well as other conductive structures present in the IPG 10 and the external controller 50. Especially when magnetic induction is used as the means for establishing communication link 75 for example, the generated AC magnetic fields will create eddy currents in such conductive structures, which essentially act as an unwanted sink for the energy in the field, thus reducing the distance at which communications and charging can reliably occur. See, e.g., USP 8,457,756.
[0016] Previous IPGs 10 have used non-conductive ceramic materials for the case 12, see, e.g., USP 7,351,921, which would reduce attenuation of wireless communications in IPGs using internal coils. However, ceramic materials are also brittle and difficult to work with. Ceramic case components further require brazing to mechanically couple them together or to other metallic components, which can be difficult to perform.
[0017] Previous approaches have used optical radiation instead of electromagnetic fields as the means to communicate with an implantable medical device. For example, USP 5,556,421 discloses a pacemaker which has photoemitter such as a Light Emitting Diode (LED), and a photodetector such as a phototransistor, for respectively transmitting data to and receiving data from a device external to the patient. See Fig. 15 of the '421 patent. However, in the '421 patent, the photoemitter and photodetector are contained within the header of the pacemaker, similar to the header 28 for the IPG 10 described earlier (Fig. 1A). The header is described in the '421 patent as suitably translucent to the wavelengths of optical radiation at which the LED and photodiode operate (within the range of 640 to 940 nm).
[0018] The inventor however finds the optical communication approach of the '421 patent to be problematic, in particular because the optical elements are contained within the header of the implantable medical device. The three-dimensional shape of the header makes optical transmission and reception difficult, as optical radiation will reflect at the outer surfaces of the header and other reflective components in the header, such as the lead connectors 26 (see, e.g., Fig. 1A). Optical radiation will also refract, attenuate, and disperse in the header material. Additionally, there may be little room in the header to accommodate optical elements. This is particularly problematic in a SCS IPG, which comprises many electrodes (e.g., 16 or 32), and hence requires long lead connectors 26, or more lead connectors, in the header 28. Providing optical elements in the header provides further concerns that additional feedthrough pins between the header and the interior of the case would be necessary, complicating IPG design and potentially impacting reliability.
[0019] USP 6,243,608 also discloses a pacemaker that can communicate optically with an external device, although once again in this reference, the optical element is contained in the header, thus suffering from the same problems discussed above with reference to the '421 patent. (Specifically, this pacemaker has only a photoemitter and thus can only communicate optically with the external device in one direction; communication from the external device to the pacemaker occurs via magnetic induction between two coils). In the text associated with one embodiment, see Fig. 6 of the '608 patent, it is mentioned that the photoemitter can be located in an electronics module inside the pacemaker case. But in this instance, the photoemitter transmits light from inside the case to the translucent header. This too is not practical. Although not discussed in detail in the '608 patent, this approach requires porting the optical radiation through the feedthrough between the case and header in some fashion, which would attenuate the radiation, and complicate feedthrough design. It is noted that a mirror may need to be provided in the header to direct the optical radiation to the external device, or that a portion of the outer surface of the header be shaped as a lens, both of which are complicated, expensive, and could be expected to attenuate the radiation.
[0020] USP 7,447,533 discloses a pacemaker in which a photoemitter and photodetector are used to detect a physiological parameter, such as blood flow (photoplethysmography). In one example, see Figs. 7 and 8 of the '533 patent, an aperture is formed in one of the flat sides of the case that accommodates an assembly containing the optical elements. Once positioned in place, the assembly is welded to the case. Nonetheless, the '533 patent is not relevant to the inventor's concern regarding communications between an implant and an external device. The optical elements in the '533 are not used to send and receive a series of data bits, and are not used to communicate optical radiation externally to the implant. Instead, the photoemitter provides radiation that reflects off the patient's tissue, which reflection is detected at the implant's photodetector to determine the physiological parameter. (If a dual-wavelength photoemitter is used, the wavelengths are enabled in an alternating fashion). For communications between the implant and the external device, the '533 patent instead uses an electromagnetic antenna operable with radio waves (e.g., 10-15 MHz). USP 5,902,326 is similar, although in this patent the optical elements are used to detect a different physiological parameter, namely blood oxygen content (oximetry).
[0021] U.S. Patent Application Publication 2009/0076353 also comprises a pacemaker having an aperture on one of the flat sides of the case that accommodates an optical sensor assembly, which again can be welded to the case. However, the unique particulars of the '353 Publication render it unsuitable for data communication external to the implant. The optical sensor assembly is designed to detect yet another physiological parameter, in this case analytes such as Potassium ions. As described in the '353 Publication, such analytes are designed to diffuse through the optical sensor assembly where they meet with a chemical sensing element. Photoemitters in the assembly are made to reflect off of this chemical sensing element. The chemical sensing element's optical properties change in the presence of the analyte, and so reflections are received at a photodetector in the optical sensor assembly to measure the analyte. Indeed, the unique particulars of this publication render it unsuitable for external data communications, as an overlying cover layer is included to block ambient light from entering the optical sensor assembly, and also to prevent the light from the photoemitters from escaping the optical sensor assembly.
[0022] The inventor is also concerned about shortcomings concerning charging an implantable medical device battery. In particular, the inventor is concerned that charging is hampered by difficulty in determining the alignment between the external charger 70 and the IPG 10.
[0023] It is generally desirable to charge the IPG's battery 14 as quickly as possible to minimize inconvenience to the patient. One way to decrease charging time is to increase the strength of the magnetic charging field 80 by increasing Icharge in the charging coil 76 of the external charger 70. Increasing the magnetic charging field 80 will increase the current/voltage induced in the coil 36 of the IPG 10, which increases the battery charging current, Ibat, hence charging the battery 14 faster.
[0024] However, the strength of the magnetic charging field 80 can only be increased so far before heating becomes a concern. Heating is an inevitable side effect of inductive charging using magnetic fields, and can result because of activation of relevant charging circuitry in the external charger 70 or IPG 10, or as a result of eddy currents formed by the magnetic charging field 80 in conductive structures in either device. Heating is a safety concern. The external charger 70 is usually in contact with the patient's tissue 100 during a charging session, and of course the IPG 10 is inside the patient. If the temperature of either exceeds a given safe temperature, the patient's tissue may be aggravated or damaged.
[0025] The alignment between the external charger 70 and the IPG 10 can affect heating, as shown in Figures 6A and 6B. In Figure 6A, the charging coils 76 and 36 in the external charger 70 and the IPG 10 are well aligned, because the axes 76' and 36' around which the coils 76 and 36 are wound are collinear. As such, these coils 76 and 36 are well coupled electrically, meaning that a higher percentage of the power expended at coil 76 in creating the magnetic charging field 80 is actually received at coil 36, which leads to higher values for Ibat. In Figure 6B, the charging coils 76 and 36 are laterally misaligned (d), which reduces the electrical coupling between the coils. Increasing the vertical distance x between the coils 76 and 36 (Fig. 6C), or increasing the angle (Θ) between the preferably parallel planes in which they reside (Fig. 6D), will also reduce coupling.
[0026] If it is desired that the alignment scenarios of Figures 6A and 6B charge the battery 14 at the same rate (Ibat = Y), then a higher value for Icharge (Icharge > X) will be needed in the misaligned scenario of Figure 6B compared to the well-aligned scenario of Figure 6A (Icharge = X). A higher value for Icharge in Figure 6B will create a more intense magnetic charging field 80 that tend to increase the temperature of the environment (T > Z) when compared to the temperature of the environment in Figure 6A (T = Z). If it is desired that the temperature be the same for both scenarios, then Icharge can be lowered in Figure 6B, but this will also lower Ibat, and hence the battery 14 in that scenario would take longer to charge. In short, misalignment between the external charger 70 and the IPG 10 is not desired.
[0027] Accordingly, the art has disclosed several manners for determining misalignment between an external charger and an IPG, which techniques usually result in some form of user-discernible output letting the patient know when alignment is poor (such as via speaker 88 discussed earlier). Such techniques may also inform a patient how to fix the alignment, such as by indicating a direction the external charger should be moved relative to the IPG 10. See, e.g., USPs 8,473,066 and 8,31 1,638.
[0028] Previous external charger alignment techniques however are difficult to implement, and may not precisely determine alignment as they rely on inferences gleaned from electrical measurements taken during the charging session. For example, one prior art alignment techniques relies on determining the loading of the charging coil in the external charger during production of the magnetic charging field. Specifically, the voltage across the charging coil (Vcoil) is reviewed at the external charger and compared to a Vcoil threshold to determine alignment. This technique though suffers in its inability to distinguish between the scenarios of Figures 6B and 6C for example. In either of these scenarios, Vcoil would be higher due to poor coupling, but in Figure 6B the poor coupling arises from misalignment, whereas in Figure 6C the alignment is as good as it can be given the IPG lO's depth (x). A modification to this technique helpful in distinguishing these scenarios requires transmitting the magnetic charging field at different frequencies and measuring the input current to the charging coil in the external charger to estimate an implant depth (x), and thus to set an appropriate Vcoil threshold. See, e.g., U.S. Patent Application Publication 2010/0137948. However, the additional overhead of having to produce magnetic charging fields at different frequencies makes this technique complicated.
[0029] Other alignment techniques require the external charger to have positioning coils in addition to the main charging coil (e.g., 76). In these techniques, measurements taken from the positioning coils during the charging session are used to determine misalignment, and to indicate a direction the external charger can be moved to improve alignment (coupling). See, e.g., USPs 8,473,066 and 8,311,638. The requirement of additional coils beyond the main charging coil though complicates the design of the external charger.
[0030] Still other alignment techniques employ electromagnetic (EM) telemetry from the IPG, see, e.g., U.S. Patent Application Publications 2013/0096651 and 2011/0087307, which adds complexity to both the IPG and the external charger. Moreover, EM telemetry may be difficult to employ while the external charger is generating a magnetic charging field (e.g., 80), because such field is relatively strong, and may add significant noise to the EM telemetry signal. Thus it may be necessary to periodically cease the production of the magnetic charging field during a charging session to allow such telemetry from the IPG to the external charger to occur, which inconveniently lengthens the duration of the charging session.
[0031] The inventor is further concerned that LSK telemetry is limited in its ability to communicate information from the IPG the external charger. First, as noted earlier, LSK telemetry is only useful when the external charger is producing a magnetic charging field, thus hampering the ability of the IPG to communicate with the external charger, prior to starting a charging session for example. Moreover, LSK telemetry may be difficult to demodulate (e.g., Fig. 5, 96). Vcoil, the parameter assessed by LSK demodulator 100, can vary in magnitude as the alignment between the external charger and IPG varies during a charging session, which is typical. Likewise, AV, the difference in Vcoil for each of the logic states being transmitted by the IPG, can vary and may also be relatively small and hard to detect depending on the coupling. SUMMARY OF THE INVENTION
[0032] An implantable medical device (IMD) for communicating with an external device is disclosed, which in one example includes window affixed to a side of the case; a photodetector within the case configured to optically receive through the window a first series of data bits transmitted from an external device; and a photoemitter within the case configured to optically transmit through the window a second series of data bits to the external device. The case can be metallic, and may have a header affixed thereto. The window may be one or more of flat, a lens, or a glassy material. The side of the case to which the window is affixed may be flat. The window can comprise a portion of a window assembly including a collar, in which the window is brazed to the collar, and in which the collar is welded to the case. The window assembly may be substantially flush with the side of the case. The photodetector and photoemitter may be operable at one or more visible wavelengths.
[0033] A disclosed system includes an IMD and an external device. The IMD includes a first case; a first window affixed to a side of the first case; a first photodetector within the first case configured to optically receive through the first window a first series of data bits; and a first photoemitter within the first case configured to optically transmit through the first window a second series of data bits. The external device comprises a second photoemitter configured to optically transmit the first series of data bits; and a second photodetector configured to optically receive the second series of data bits. The first and second photodetectors and photoemitters may be operable at least at one or more visible wavelengths. The external device may be configured to allow a user to set or adjust therapy the implantable medical device provides via the first series of data bits.
[0034] The external device may further include a second case, in which the second photoemitter and the second photodetector are provided through one or more holes in the second case or are located on an outside of the second case. Alternatively, second case of the external device can include a second window affixed to the second case, in which the second photoemitter is configured to optically transmit the first series of data bits through the second window, and in which the second photodetector configured to optically receive the second series of data bits through the second window. The external device may alternatively comprise a mobile controller with a graphical user interface and a communication head, in which the second photoemitter and the second photodetector are located on or in the communication head. The external device may also include a charging coil configured to produce a charging field to charge a battery in the IMD, and the second series of data bits may be used by the external device to control the charging field.
BRIEF DESCRIPTION OF THE DRAWINGS
[0035] Figures 1A and IB show an Implantable Pulse Generator (IPG) and the manner in which electrodes are affixed in accordance with the prior art.
[0036] Figures 2A and 2B show an external controller for an IPG and the manner in which they communicate in accordance with the prior art.
[0037] Figure 3 shows the communication circuitry in the external controller and the IPG in accordance with the prior art.
[0038] Figures 4A and 4B show an external charger for an IPG and the manner in which they communicate in accordance with the prior art.
[0039] Figure 5 shows the communication circuitry in the external charger and the IPG in accordance with the prior art.
[0040] Figures 6A-6D show different alignment scenarios between the external charger and the IPG in accordance with the prior art.
[0041] Figures 7A and 7B show an improved IPG having a window assembly for optical communications.
[0042] Figures 8A and 8B show the improved IPG in cross section.
[0043] Figure 9 shows an improved external controller for optically communicating with the improved IPG.
[0044] Figure 10 shows the optical communication circuitry in the improved external controller and the improved IPG.
[0045] Figure 1 1 shows a modified improved external controller having an optical communication head.
[0046] Figure 12 shows an improved external charger for communicating with the improved IPG.
[0047] Figure 13 shows the optical communication circuitry in the improved external charger and the improved IPG.
[0048] Figures 14A-14C show use of the optical communication circuitry to determine external charger / IPG alignment.
[0049] Figures 15A- 15D show use of the optical communication circuitry to determine a direction of external charger / IPG misalignment. [0050] Figure 16 shows a modified improved external charger having a charging head with optical communication capabilities.
[0051] Figure 17 shows an improved combined external controller / charger for optically communicating with the improved IPG.
[0052] Figure 18 shows a modified improved combined external controller / charger having a combined communication /charging head.
DETAILED DESCRIPTION
[0053] The inventor discloses an improved medical device system in which system devices communicate optically. An Implantable Medical Device (IMD) such as an IPG is disclosed having a hermetic window assembly on one side of its case, through which a photoemitter and photodetector can directly transmit and receive optical signals to and from the outside of the patient. The optical radiation in the optical signals is preferably visible, which permits communications from the IMD to be seen prior to implantation and even after implantation through a patient's tissue. External controllers for adjusting therapeutic operation of the IMD, external chargers for providing a magnetic charging field to charge a battery in the IMD, and combined external controllers / chargers are also disclosed that optically bi-directionally communicate with the IMD through the patient's tissue, all of which may include distal communication heads which perform optical communications with the IMD, and which may also include a charging coil. The optical communication capabilities of the external charger are particularly useful in determining and indicating misalignment with the IMD, and optical communications can occur between the external charger and the IMD regardless whether the external charger is producing a magnetic charging field or not, and without the need to cease production of the magnetic charging field. Such optical communications can also displace legacy Load Shift Keying means of communicating with the external charger, which can be difficult to demodulate.
[0054] An improved IPG having optical communication capabilities is discussed first (Figs. 7A-8B). External devices that can optically communicate with the improved IPG 110 are then discussed, such as an improved external controller (Figs. 9-1 1), and an improved external charger (Figs. 12-16). An integrated external device combining both communication and charging capabilities that can optically communicate with the improved IPG is discussed last (Figs. 17-18).
[0055] Figure 7A shows an improved IPG 110 having an optical window assembly 112 on a top flat side of its case 12 that will face outwardly of the patient when implanted. Underlying and generally centered with the window assembly 1 12 are optical devices, namely a photoemitter 114 and a photodetector 116, as seen in Figure 7B (with the case 12 removed). As shown in the cross section of Figure 8A, the photoemitter 1 14 and a photodetector 116 are electrically coupled to the PCB 30 of the IPG 1 10. Photodetector 116 may be a photo-sensitive transistor in one example, and photoemitter 1 14 may comprise a Light Emitting Diode (LED) or a laser diode, although other types of optical devices may also be used. As will be explained further below, having both a photoemitter 1 14 and photodetector 1 16 enables the IPG 110 to optically communicate in two directions (101a and 101b). However, this is not strictly necessary, and in uni-directional applications, only one of these devices 114 and 116 may be needed.
[0056] Figure 8B shows further details of the construction of the window assembly 112, and the manner in which it is affixed to the case 12. The window assembly 112 comprises a biocompatible material and may be comprised of a glassy material, such as Schott BK10, Corning 7056, sapphire, fused silica, or quartz for example. The window 1 18 is made to fit in a ring-shaped collar 122 comprising titanium for example, or any other biocompatible material affixable to the material of the case 12. A filler material 120, such as gold or glass, fills the seal between the window 1 18 and the collar 122, and brazing is performed to melt the filler 120 and create a hermetic seal between the window 118 and the collar 122. Other brazing filler materials 120 could be used as well. As shown, the collar 122 may include a step to keep the window 118 and filler material 120 in place during the brazing process.
[0057] The side of IPG 110's case 12 is formed with a hole 13 to accommodate the window assembly 1 12 once its manufacture is completed. In this example, the case 12 and collar 122 include steps to allow the window assembly 1 12 to be placed within the hole 13 without falling through. Once positioned in place, the window assembly 1 12 can be welded 124 to the case 12 to create a hermetic seal. As depicted, the window assembly 1 12 is substantially flush with the outside surface of the case (e.g., less than 10 mils difference), which is preferred to prevent aggravation of tissue that the window assembly 112 will contact.
[0058] This design for window assembly 1 12, and the manner in which it is affixed to the case 12, are merely examples. Other designs and methods for providing a window 118 in an implantable medical device case 12 with good hermeticity can be used.
[0059] The photoemitter 114 and a photodetector 1 16 are positioned to receive and transmit optical radiation through the window 118 in the window assembly 112. In preferred embodiments, the photoemitter 114 and a photodetector 1 16 operate at visible wavelengths (e.g., from approximately 380 to 740 nm). This is particularly preferred when a patient, clinician, or manufacturer desires to see optical radiation emitted from the IPG 110, which is useful in several circumstances explained below. However, in other examples, the photoemitter 1 14 and a photodetector 116 can operate at non- visible wavelengths, such as near-Ultraviolet (e.g., 10 nm - 400 nm) and near-Infrared wavelengths (e.g., 700 to 2500 nm). Essentially, any wavelength of optical radiation can be used in the context of IPG 110, so long as it (1) is not significantly attenuated by the window 118 and the patient's tissue 100, and (2) does not risk damaging the patient's tissue 100.
[0060] Because the photoemitter 1 14 and a photodetector 116 are hermetically sealed inside the case 12 with other IPG electronics, special care does not need to be taken to ensure that such devices are biocompatible, and thus typical, inexpensive, off-the-shelf optical components can be used for each. Photoemitter 1 14 and photodetector 1 16 may comprise a number of emitters or detectors, which may be integrated into a single optical device, although they are illustrated here separately here for clarity. Photoemitter 1 14 may additionally emit optical radiation at different wavelengths (e.g., different colors), while photodetector 116 may likewise be sensitive to such wavelengths.
[0061] Note that the inclusion of photoemitter 1 14 in the IPG 110 provides several benefits. During manufacturing or even during implantation when the IPG 1 10 is not yet covered by a patient's tissue 100, the photoemitter 114 (particularly if it operates at visible wavelengths) provides an easy means of verifying IPG 110 operation. For example, a manufacturer of IPG 110 can test the device and receive optical feedback concerning IPG operation by viewing the illumination of photoemitter 114 through the window assembly 1 12. Visual feedback can come from the photoemitter 114 in any number of forms. For example, a green light may indicate proper IPG 110 operation, and a red light may indicate faulty operation, etc. Various operational conditions can also be visually indicated. For example, a solid light may indicate one condition, a slow blinking pulse a second condition, a fast blinking pulse a third condition, etc. Combinations of blinking pulses can visually indicate various operational codes, including failure codes. For example, repeating a single pulse might indicate a first code; repeating two pulses might indicate a second code, etc. Combinations of these types of visual feedback can also be used to indicate operation, conditions, or codes. Such visual feedback can be issued by the IPG 110 of its own accord, or in response to a communication sent from the external controller 150 (Fig. 9), the external charger 170 (Fig. 12), or other external device. [0062] A clinician can also benefit from such visual feedback provided by IPG 110. For example, when the clinician attaches the leads 18 (Fig. 1A) to the lead connectors 26 during surgery, it is important to verify that good electrical contact is established, and that there are no open or short circuits at any of the electrode contacts 16. This can be visually indicated to the clinician via photoemitter 114 before surgery is complete, in any of the foregoing manners.
[0063] A patient may also benefit from visual feedback even after the IPG 110 has been implanted in her tissue 100. In this regard, and referring to Figure 8A, photoemitter 1 14 will illuminate a portion 101 of the patient's tissue 100 after implantation. The optical radiation will scatter and attenuate in the illuminated tissue 101, particularly if the IPG 1 10 is implanted deeper in the patient (x). Still, many implantable medical devices, including SCS IPGs 110, are purposely implanted reasonably close to the patient's skin to make implanting and explanting easier, which would reduce optical attenuation. If optical attenuation is significant enough that optical radiation from the photoemitter 114 cannot been seen at the surface of the patient's skin, the power of the photoemitter 114 can be increased. Alternatively, a patient may be instructed to view the illuminated tissue 101 in a darker environment to review relevant IPG operations, conditions, or codes.
[0064] If necessary, the window 1 18 in the window assembly 112 can be formed as a lens, instead of flat, to better focus the optical radiation, and to reduce the volume of the illuminated tissue 101 in which the optical radiation disperses. For example, use of a convex lens 1 18 would tend to focus optical radiation in the illuminated 101 tissue if radiation emitted from the photoemitter 114 is not well collimated. A convex lens 118 would also focus optical radiation dispersed in the illuminated tissue 101 toward the photodetector 116 when receiving radiation in the other direction, as subsequently explained. Traditional bulk lenses or Fresnel lenses could be used for window 118.
[0065] It should also be noted that window 1 18 need not be significantly optically translucent, or "see through," as glass would generally be to visible light for example. Instead, window 1 18 could be made of otherwise generally opaque materials that are still able to pass significant amounts of optical radiation in and out of the IPG 1 10. For example, window 118 could comprise a ceramic material, which could pass suitable amounts of optical radiation if made thin enough, and/or if the power and sensitivity of the photoemitter 1 14 and photodetector 1 16 are suitably high. In short, window 1 18 may be comprised of any material able to pass suitable amounts of optical radiation to enable the various means of optical communications disclosed, and "window" should not be construed to cover simply translucent materials.
[0066] Through-the-skin visual indications can occur in any of the ways discussed above, and can provide different sorts of information to the patient. For example, a patient could be provided with a card describing various indications important to IPG 1 10 operation. For example, a first indication might denote a first type of fault in the IPG 1 10; a second indication a second type of fault, etc. A flashing red light might indicate potentially unsafe stimulation setting, while a solid red light indicates a severe failure that caused the IPG 110 to shut down. Red indications may denote that the patient needs to contact the clinician, while green indications indicate normal IPG operation while still providing particular information.
[0067] Through-the-skin visual feedback can also be used to indicate information relevant to the battery 14 in the IPG 1 10, such as when it needs to be recharged. In one simple example illustrated in Figure 6A, the photoemitter 114 may pulse 102 when charging is required (when Vbat is low. More complicated visible feedback scenarios are also possible, such as changing the pulse frequency (f) as a function of Vbat. Such pulses 102 can be of constant intensity (I) over their pulse width (pw), or could also include modulated data interpretable by the external controller 150 (Fig. 9) or the external charger 170 (Fig. 12). For example, pulses 102 could include data such as an instruction to the external charger 170 start charging and/or the level of the battery 14 (Vbat). Pulses 102 could also include error codes interpretable by the external controller 150, which the patient could review on that device's graphical user interface. Such data modulation within pulses 102 may occur on a time scale not visually resolvable by the patient, who instead may simply see single pulses 102 despite the data included within them. Data-modulated portions of pulses (if any), may be small compared to the pulse width of the pulses, and can occur at the end or beginning of such pulses, or may be interleaved with pulses of constant intensity. Although the pulses 102 are shown as periodic, they don't have to be. Moreover, using photoemitter 114 in the IPG 110 to produce visual feedback, or pulses 102 specifically, is not strictly required.
[0068] Figure 9 shows an improved external controller 150 operable to optically communicate with the improved IPG 1 10, which in this example comprises modifications to the external controller 50 disclosed earlier (Fig. 2A). Like the external controller 50 described earlier, external controller 150 is used to set or adjust the therapy settings the IPG 110 will provide to the patient, and to receive relevant data from the IPG 110. [0069] External controller 150 includes an optical window assembly 163 formed in the bottom of its case 59 that will face inwardly of a patient during a communication session between the external controller 150 and the IPG 110. External controller 150 further includes a photoemitter 164 and a photodetector 166 affixed to its PCB 51 which are generally centered with the window assembly 172. As with the IPG 1 10, external controller 150 may have only one of photoemitter 164 or photodetector 166 in a uni-directional application. Because the external controller 150 is not governed by the same hermeticity requirements as the IPG 1 10, the manner in which the window assembly 172 is affixed to a hole in the case 59 is less critical, and can occur in any manner suitable for an external device.
[0070] Moreover, the photoemitter 164' and photodetector 166' can also be modified to pass through one or more holes in the case 77, or photoemitter 164" and a photodetector 166" may be located outside of the case 77, with their lead wires passing through one or more smaller holes in the case, as shown in the bottom of Figure 9. Coatings or epoxies can be useful to hold the photoemitters 164' or 164" the photodetectors 166'or 166' to the case 77 and for mechanical protection in these modification. Despite such modified placement of these optical devices of the external controller 150, the subsequent discussion focuses for simplicity on placement using a windows assembly 153, even though these modified placements could be used subsequently as well.
[0071] The photoemitter 164 and photodetector 166 in the external controller 150 may operate at the same wavelengths described earlier for the photoemitter 114 and a photodetector 116 in the IPG 110. Photoemitter 164, like photoemitter 164, will illuminate tissue 101 at a sufficient depth (x) to reach the optical window assembly 112 of the IPG 110. As such, at least some amount of the optical radiation from photoemitter 164 in the external controller 150 will reach the photodetector 116 in the IPG 110, and at least some amount of the optical radiation from photoemitter 1 14 in the IPG 110 will reach the photodetector 166 in the external controller 150. This allows the two devices 1 10 and 150 to bi-directionally optically communicate through the patient's tissue 100.
[0072] The window assembly 153 can appear anywhere on the external controller 150, but the window assembly 112 of the IPG 110 is preferably generally centered with its charging coil 36. This placement of window assembly 1 12 is useful if the IPG 110 is additionally charged by an external charger 170 (Fig. 12) that employs optical communications, as described below. Another place where the window assembly 153 ' and its corresponding photoemitter 164 and photodetector 166' may be placed on the external controller 150 is on its edge next to the port 58 (Fig. 2A) as shown in dotted lines, which may make accessing the user interface of the external controller 150 easier during a communication session with the IPG 1 10. As with the window assembly 112 of the IPG 110, the window assembly 153 could comprise a lens to better focus optical radiation emitted from photoemitter 164, or received at photodetector 166, and may be comprised of any material able to pass suitable amounts of optical radiation.
[0073] The window assembly 153 of external controller 150 preferably touches the patient's tissue 100 during a communication session in the center of the IPG 1 10, or at the illuminated tissue 101 if photoemitter 114 in the IPG 1 10 is providing visual feedback as discussed earlier. It is helpful to reduce ambient light in any space 149 between the external controller 150 and the tissue 100 that could otherwise interfere with optical communications, although if the optical devices in both are tuned to specific wavelengths, this is not as critical. Optical communications can still be had through a patient's clothing if it permits sufficient optical radiation to pass through.
[0074] Figure 10 shows circuitry that can be used for bi-directional optical communications between the external controller 150 and the IPG 110 via optical communication links 101a and 101b (comprising the illuminated tissue 101), which are used to optically transmit and receive a series of digital data bits 147. Such circuitry includes optical transmitters (144, 134) coupled to the photoemitters (164, 114) in the external controller 150, and optical receivers (146, 136) coupled to the photodetectors (166, 116) in the IPG 110. The optical transmitters 144 and 134 may include necessary modulation circuitry to convert the digital data bits 147 into appropriate modulated analog signals to drive the photoemitters 164 and 1 14 per the modulation scheme chosen. The optical receivers 146 and 136 may likewise include necessary demodulation circuitry to convert the modulated analog signals received at the photodetectors 166 and 1 16 into the series digital data bits 147 per the same modulation scheme.
[0075] The optical data modulation scheme used in the optical transmitters 144 and 134 can include Phase Shift Keying (PSK), which can occur at 9600 bits-per-second in one example. See, e.g., K. Inoue et al, "Transcutaneous Optical Telemetry System with Infrared Laser Diode," ASAIO J. at 841 (1998), which is submitted in the Information Disclosure Statement filed herewith. If PSK is used as the modulation scheme, the optical receivers 146 and 136 could comprise Phase Locked Loops (PLLs) for example. However, use of PSK modulation is merely one example. For example, Pulse Width Modulation (PWM), On-Off Keying (OOK), Differential Phase Shift Keying (DPSK), Pulse Amplitude Modulation (PAM), Quadrature Amplitude Modulation (QAM), M-ary varieties of the foregoing, etc., could also be used. The nature of optical communications would also allow for significant higher bit rates, although 9600 bits-per-second would generally be sufficient for communications between the external controller 150 and the IPG 110.
[0076] The optical receivers 146 and 136 in the external controller 150 and IPG 1 10 may not be strictly necessary, or could be modified. For example, if control circuitries 60 and 38 are additionally programmed to provide necessary demodulation functionality, the optical receivers 146 and 136 may comprise Analog-to-Digital (A/D) converters that can digitize the analog intensity signal provided by the photodetectors 176 and 1 16, and provide these digitized intensity values to their respective control circuitries 60 and 38 to determine the individual data bits. If the control circuitries 60 and 38 provide A/D inputs capable of digitizing the data, separate optical receivers 146 and 136 may not be necessary at all, and the control circuitries can be programmed to perform the demodulation. Likewise discrete optical modulators 144 and 134 may also be modified or may not be required if control circuitries 60 and 38 are additionally programmed to provide necessary modulation functionality, or if they include D/A outputs that can drive the photoemitters 114 and 164 directly.
[0077] The optical receivers 146 and 136 in the external charger 170 and IPG 1 10 can vary in design depending on whether what is important in received optical signals is modulated data (D), intensity (la), or both, which may also depend of the modulation scheme being used. For example, received intensity la would be important in modulation schemes employing amplitude modulation, and can be important if a received optical signal is of constant intensity and without data, as discussed further below. In this regard, the optical receivers 146 and 136 can also report such received intensities la to the control circuitries 60 and 38 along with any digital data. Received intensity may involve filtering or integrating the analog signal from the photodetectors 166 or 166 either before or after they are digitized, or may be gleaned by processing in the control circuitries 92 and 38.
[0078] Figure 1 1 shows another embodiment of an external controller 150' system that can optically communicate with IPG 110. In this example, optical components have been moved out of the external controller 150 (compare Fig. 9), and into an optical communication head 210, including the photoemitter 164, the photodetector 166, and if necessary, optical transmitter and receiver circuitry 144 and 146. These components may be integrated on a PCB 216, and contained within a housing 218, which may be significantly smaller and less complicated that the housing 59 used by the external controller 150. As shown, the optical communication head 210 includes a window assembly 153, similar to that described earlier for external controller 150, but could include the other optical device placement options discussed in Figure 9.
[0079] The optical communication head 210 communicates with a mobile controller with a graphical user interface, such as the external controller 50 described earlier (Fig. 2A), or a mobile device 200 such as a cell phone, a tablet computer, or another hand-holdable portable control device. As depicted, the optical communication head includes a cable 212 and a connector 214 that can couple to appropriate ports 58 (Fig. 2A) or 208 on the mobile controller. However, such wired connection of the optical communication head 210 is not necessary, and instead it may communicate with the external controller 50 or mobile device 20 wirelessly using a suitable short-range protocol, such as Near Field Communication (NFC), Bluetooth, Bluetooth Low Energy (BLE), Wifi, Zigbee, etc, that is supported by the mobile controller. If such wireless communications were used, the optical communication head 210 may also additionally include a battery (as it could not receive power from the mobile controller by the cable 212), and telemetry circuitry compliant with the short-range protocol used. As disclosed in U.S. Provisional Patent Applications Serial Nos. 61/873,314, filed September 3, 2013, and 61/874,863, filed September 6, 2013, which are both incorporated herein by reference in their entireties, the mobile device 200 can include an executable application to provide a graphical user interface, which like external controller 50 can allow a patient to set or adjust the therapy settings the IPG 1 10 will provide to the patient, and to receive relevant data from the IPG 1 10.
[0080] Under control of the graphical user interface provided by the mobile controller, digital data bit to be transmitted to the IPG 1 10 can be serialized and sent to ports 58 or 208 and down the cable 212 to the head 210, or the data can be wirelessly transmitted from the mobile controller via a short-range protocol and recovered at the head 210. Once received at the head 210, the data is modulated at optical transmitter 144, with the modulated data driving photoemitter 144 in the head to provided optical data to the IPG 110 via link 101a. Optical data received from the IPG 110 via link 101b is received at photodetector 166 in the head 210, and is demodulated at optical receiver 146 to recover the series of digital data bits. Thereafter, the head 210 can provide the bits to the mobile controller via the cable 212, or wirelessly using the short range protocol. Note that providing optical transmitter and receiver circuitry 144 and 146 in the optical communication head 210 is not strictly necessary if the mobile controller can provide the proper signals at the ports 58 and 208 to drive and receive data from the photoemitter 164 and photodetector 166 directly. [0081] The external controller 150' of Figure 11, while having different pieces, may be more convenient for a patient, because it allows the optical communication head 210 to be placed proximate to the IPG 1 10 (such as in a belt with a pocket, or adhered to the patient's tissue 100 using double sided tape), while the mobile controller can remain relatively distant from the IPG 110 by virtue of the length of cable 212 or the length of the short-range protocol. This makes IPG optical communications easier, particularly if the IPG 1 10 is located in an area behind the patient, as occurs in an SCS application, as it permits the graphical user interface of the mobile controller to be held and seen in front of the patient. If the optical communication head 210 is held in place with a pouch, provisions can be made in the pouch to render it transparent to the optical radiation used to communicate between the head 210 and the IPG 1 10, such as by forming the patient- facing wall of the pouch with transparent plastic or a mesh material, by providing a hole in the patient-facing side for the optical window 153, etc.
[0082] The design of IPG 1 10 and external controllers 150 and 150' provide reliable means for optically communicating through the patient's tissue 100. The path optical communications take in the disclosed devices is direct compared to more-complicated prior art optical communication approaches discussed earlier. For example, when transmitting from the IPG 110 to the external controller 150, optical radiation generated at photoemitter 114 passes straight to a flat and relatively thin window 1 18 in window assembly 1 12 and thus will experience little attenuation in the IPG 110, as the optical radiation need not pass through curved or bulky translucent materials (like header 28) that can reflect or refract such radiation, or which contain additional components that could interfere with such radiation (such as feedthroughs, lead connectors, mirrors, etc.). The window assembly 112 is beneficially provided on a side of the IPG case that is already naturally facing outwardly of the patient when implanted, thus sending optical radiation trough the tissue 100 in a direct route out of the patient without re-direction and with little attenuation. After passing through the patient's tissue in this manner, the radiation again experiences little attenuation coming into the external controller 150, as it travels straight through another thin, flat window assembly 153 overlying photodetector 166, or directly to the photodetector 166 if alternatively mounted to the external controller 150 (see Fig. 9). Moreover, this optical communication path can be symmetric, as the window assemblies 153 and 112, the optical components, and their positions relative to the window assemblies can be essentially the same. These factors result in optical communications that can be transmitted with the same low levels of energy at both devices. [0083] Discussion now turns to external charging, and to an improved external charger 170 that can optically communicate with the IPG 110. Figure 12 shows the improved external charger 170, which includes an optical window assembly 172 formed in the bottom of its case 77 that will face inwardly of a patient during a charging session. External charger 170 further includes a photoemitter 174 and a photodetector 176 affixed to its PCB 72 which are generally centered with the window assembly 172, although again, only one of photoemitter 174 or photodetector 176 may be required in a uni-directional application. Because the external charger 170 is not governed by the same hermeticity requirements as the IPG 110, the manner in which the window assembly 172 is affixed to a hole in the case 77 is less critical, and can occur in any manner suitable for an external device. Moreover, the photoemitter 174 and photodetector 176 can be positioned through or on the bottom of case 77, as discussed with respect to the external controller 150 of Figure 9, although these modifications are not again depicted for simplicity. Again, the window assembly 172 could comprise a lens to better focus emitted and received radiation, and may be comprised of any material able to pass suitable amounts of optical radiation.
[0084] The photoemitter 174 and photodetector 176 in the external charger 170 may operate at the same wavelengths described earlier for the photoemitter 114 and a photodetector 116 in the IPG 1 10. Photoemitter 174, like photoemitter 114, will illuminate tissue 101 at a sufficient depth (x) to reach the optical window assembly 1 12 of the IPG 110. As such, at least some amount of the optical radiation from photoemitter 174 in the external charger 170 will reach the photodetector 116 in the IPG 110, and at least some amount of the optical radiation from photoemitter 114 in the IPG 1 10 will reach the photodetector 176 in the external charger 170. This allows the two devices 1 10 and 170 to bi-directionally optically communicate through the patient's tissue 100.
[0085] The window assembly 172 can appear anywhere on the external charger 170, but is preferably generally centered with its charging coil 76 as shown. As will be discussed further below, this is useful in optically determining external charger / IPG alignment. It should however generally be easy for the patient to align the external charger 170 with the IPG 1 10 in preparation for a charging session. For example, if the patient sees pulses 102 (Fig. 8A) illuminating her tissue 101, this may indicate that the battery 14 in the IPG 1 10 is low, and that charging is required. The patient can thus visually place the window assembly 172 on the bottom of the external charger 170 over the illuminated tissue 101, as shown in Figure 12. The external charger 170 generally touches the patient's tissue 100 during a charging session to reduce ambient light that could otherwise interfere with optical communications, as described earlier. As such, the external charger 170 will tend to block such ambient light, and as a result, a less-powerful photoemitter 174 and less-sensitive photodetector 176 may be used in external charger 170 when compared to such optical devices in the external controller 150 described earlier. Optical communications can still be had with the external charger 170 through a patient's clothing or using a modified pouch as described earlier.
[0086] Figure 13 shows circuitry that can be used for bi-directional optical communications between the external charger 170 and the IPG 1 10 via optical communication links 101a and 101b (comprising the illuminated tissue 101), which includes optical transmitters (184, 134) coupled to the photoemitters (174, 114), and optical receivers (186, 136) coupled to the photodetectors (176, 1 16). The optical data modulation scheme used in the optical transmitters 184 and 134 can again include Phase Shift Keying (PSK) or any of the other modulation schemes mentioned earlier with respect to the external controller 150. In short, the optical components in the external charger 170 can largely mimic those appearing in the external controller 150 described earlier.
[0087] The external charger 170 and IPG 110 can communicate optically whether or not the external charger 170 is producing a magnetic changing field 80 to charge the IPG 1 10's battery 14 during a charging session. This is in distinction to LSK communications, which as noted earlier can only occur while the magnetic charging field 80 is produced. Moreover, optical communications will not interfere with the magnetic charging field 80 and so can occur during a charging session, unlike systems that use EM telemetry schemes to determine alignment that were discussed earlier.
[0088] The external charger 170 and IPG 1 10 can optically communicate for many useful reasons. For example, the IPG 1 10 can send an optical signal with data via link 101b to instruct the external charger 170 to start generating a magnetic charging field 80 or to send the battery voltage Vbat, which as already noted may be included in pulses 102 (Fig. 8A). Other examples of optical communications along link 101b are discussed in detail below.
[0089] The external charger 170 can also optically communicate data to the IPG 110 along link 101a. For example, the external charger 170 when positioned over the IPG 110 can optically send an instruction to the IPG 1 10 to report its battery capacity, Vbat, along link 101b, which may be beneficial if pulses 102 are not used to indicate Vbat, or if pulses 102 are merely of constant intensity and do not contain data such as Vbat. Once Vbat is then optically reported from the IPG 1 10 to the external charger 170, the external charger 170 can initiate a charging session by generating a magnetic charging field 80 if necessary (i.e., if Vbat is low). Alternatively, the external charger 170 may optically send further instructions to the IPG 110 via link 101a informing the IPG 1 10 of the desired to begin charging, with such charging commencing only after the external charger 170 optically receives an acknowledgement from the IPG 1 10 via link 101b. This might be desired to allow the IPG 110 time to prepare itself for charging. Link 101a can also be used during a charging session. For example, the external charger 170 might periodically provide information to the IPG 110 during the charging session, such as an estimation of how much longer the external charger 170 believes charging may last. Alternatively, the external charger 170 may not have a photoemitter 174, and thus may only allow for one-way optical communications from the IPG 1 10 (via link 101b).
[0090] Once the IPG 110 starts receiving the magnetic charging field 80, it preferably periodically optically sends data to the external charger 170 via link 101b, which is shown in Figure 13 as pulses 103. Pulses 103 may be the same as pulses 102 (Fig. 8A), which may simply continue after receipt of the magnetic charging field 80, and which may now contain additional data relevant to the charging session. Pulses 103 may include for example the IPG's battery voltage (Vbat), the temperature of the IPG (T), information indicative of the electrical coupling between the external charger 170 and the IPG 110 such as the battery charging current (Ibat), or all of these or still other parameters relevant to the current charging session. Again, although pulses 103 are shown as periodic, they don't have to be, so long as they are sent with a suitable frequency to allow the external charger 170 to optically receive data on a reasonable time scale during the charging session (e.g., every second).
[0091] The external charger 170 may use such optically -received data to control the magnetic charging field 80 it is producing. For example, if the external charger 170 understands that the optically-reported temperature data (T) from the IPG 1 10 is above a threshold for example, it can reduce the energy of the magnetic charging field 80, for example by lowering Icharge, or by reducing the duty cycle of the field. See, e.g., U.S. Patent Application Publication 201 1/0087307. The external charger 170 can also monitor optically-reported coupling data (e.g., Ibat), and adjust the magnetic charging field 80 accordingly, for example by increasing Icharge or the duty cycle if Ibat is lower than a threshold, or by reducing these magnetic charging field parameters if Ibat is higher than a threshold. Monitoring optically-reported data for Vbat may also be used by the external charger 170 to control the magnetic charging field 80 or to monitor the progress of charging generally, as well as to understand when Vbat is fully charged (e.g., to a threshold), so that generation of the magnetic charging field 80 can cease. [0092] Optical communications can also be used in determining external charger 170 / IPG 1 10 alignment, which as noted earlier is important to ensure fast IPG battery charging without overheating. Additional circuitry is shown in Figure 14A to assist with the determination of alignment, including an alignment detector, which in the example shown comprises an intensity module 190 programmed in the external charger 170's control circuitry 92. In this example, alignment is determined by assessing the received intensity (la) of optical signals transmitted by the photoemitter 1 14 in the IPG 110, and detected at the photodetector 176 in the external charger 170 via optical link 101b. Optical receiver 186 in the external charger 170 can be configured to provide the received intensity, la, as describer earlier in conjunction with the external controller 150.
[0093] These optical signals are shown as alignment pulses 104 in Figure 14A, and can comprise the same pulses 102 or 103 discussed earlier, and thus may contain modulated data (D). If the pulse width (pw) of pulses 104 is relatively large compared to portions that might contain optically-modulated data, the presence of such data in pulses 104 should not affect their received intensities, la. Alternatively, pulses 104 may comprise pulses of constant intensity over its pulse width. Pulses 104 can also be discrete from pulses 103 (Fig. 13), and may be interleaved with these pulses during a charging session. As with earlier pulses, pulses 104 do not have to be periodic, but are preferably sent with a suitable frequency to allow the external charger 170 to receive data on a reasonable time scale to assess alignment in real time from the patient's perspective (e.g., every second).
[0094] In this example, the photoemitter 1 14 in the IPG 110 issues optical pulses 104 during a charging session of a known intensity, I. As the pulses 102 pass through the illuminated tissue 101 (101b), they will attenuate, and thus will be received at the external charger 170 with a lower intensity, la. This intensity la can be determined at the optical receiver 186 in the external charger 170 as explained earlier.
[0095] Once la is received, it is presented to intensity module 190, which compares la to an intensity threshold, Ith, to determine if la is lower than it should be, which may warrant a conclusion that the external charger 170 is misaligned with respect to the IPG 1 10. Figures 14B and 14C show the effect of external charger 170 / IPG 1 10 alignment on received optical intensity, la. In Figure 14B, the external charger 170 and IPG 1 10 are well aligned, and the axes through their window assembly 172 and 1 12 are collinear. Because the window assemblies 172 and 112 are also generally centered with respect to charging coils 76 and 36 respectively, these coils 76 and 36 are thus also collinear, which as noted earlier (Fig. 6A) represents good alignment and electrical coupling between the external charger 170 and IPG 110. When well aligned, the window assembly 172 of the external charger will cover a broader area of the tissue 101 illuminated by the photoemitter 1 14 in the IPG 1 10, and thus the photodetector 176 in the external charger 170 will receive a larger amount of optical radiation (i.e., Ia > Ith), and thus la will be relatively high.
[0096] By contrast, in Figure 14C, the window assembly axes and the charging coils are not collinear; the window assembly 172 covers a smaller area of the illuminated tissue 101 ; photodetector 176 receives a smaller amount of optical radiation; and Ia is relatively low (e.g., Ia < Ith), indicating poor alignment and coupling. Should the intensity module 190 detect this condition, it can notify the patient of the misalignment condition using speaker 88 as described earlier so that the patient can readjust the position of the external charger 170.
[0097] An IPG can be implanted at different depths (x; Fig. 8A) in different patients, and so the received intensity Ia may vary from patient to patient. Thus, the intensity threshold, It, is preferably established for a given patient during a training or learning phase. For example, when first using the external charger 170, a patient may be instructed to very carefully align the two window assemblies 172 and 112, to press the external charger 170 firmly against her tissue 100, and to turn on the external charger 170 to start generating a magnetic charging field 80. The external charger 170 can then assess the strength of Ia for this known good alignment condition, and then set Ith in the intensity module 190 at an appropriate lower value.
[0098] Figures 15A-15D illustrate a different embodiment of an external charger 170' that as well as determining alignment optically can also determine a direction in which the external charger 170' is misaligned with respect to the IPG 1 10, and indicate this to the patient to assist in adjustment. In Figure 15 A, the bottom side of the external charger 170' includes a larger window assembly 172, and mounted to the PCB 72 are a number of photodetectors 176x arranged radially around a central photoemitter 168, and also arranged radially with respect to the charging coil 76 (Fig. 7). Figure 15B shows the photodetectors 176x at the same locations, but with each having its own window assembly 172x in the external charger's case 77. A central photodetector could also be present at the central location of the photoemitter 174 to assist in communications or alignment as described earlier, but this is not shown.
[0099] In either example, the photodetectors 176x will receive different intensities Iax from the central photoemitter 114 in the IPG 1 10 depending on external charger 170' / IPG 110 alignment. An underlying IPG 1 10 is shown in dotted lines in Figure 15A to illustrate this. Notice that photodetector 176i is relatively aligned with the window assembly 112 and photoemitter 114 in the IPG 110, and thus will receive a relatively strong intensity ¾. Photodetectors 1762 and Π63 are more distant, and will receive smaller intensities ¾ and ¾. Photodetector 1764 is far away from the IPG window assembly 1 12, and thus will receive a small intensity Ia4, which may be zero.
[00100] As shown in Figure 15C, optical receivers 186x corresponding to the photodetectors 176x in the external charger 170' report these intensity values Iax to the control circuitry 92. Although separate optical receivers 186x are shown, a single optical receiver 186 could also be used to sample the received intensities Iax from the various photodetectors 176x at different points in time.
[00101] The control circuitry 92 is programmed with a position determination module 194 that assesses the reported intensities Iax to triangulate the position of the external charger 170' with respect to the IPG 110, and to indicate misalignment to the patient. Such misalignment indication can include use of the speaker 88 as discussed earlier, but in addition direction indicators 196x are used to inform the patient in which direction the external charger 170' should be moved to improve alignment and electrical coupling with the IPG 1 10 during the charging session. These direction indicators 196x in one example can comprise LEDs on the top face of the external charger 170' that may (but need not) generally coincide with the location of the photodetectors 176x as shown in Figure 15D.
[00102] Continuing the example misalignment condition of Figure 15A in Figure 15D, upon determining that the photoemitter 1 14 in IPG 1 10 is near photodetector 176i, somewhat near photodetectors 1762 and Π63, but far from photodetector 1764, the position determination module 194 may light LED 196i with a strong brightness, LED 1902 and I963 with a moderate brightness, and 1964 with a low brightness, to indicate the direction that the patient should move the external charger 170', i.e., to the north-east as shown by the arrow in Figure 15D. In other words, the position determination module 194 can control the direction indicators 196x in accordance with the receive intensities values Iax, and may do so in manners other than by controlling their brightness, such as by pulse rate or color. If alignment pulses 104 are provided frequently enough to the external charger 170', control of the LEDs 196 by the position determination module 194 can occur in essentially real time to allow a patient to visually assess their progress toward achieving better alignment as she moves the external charger 170' by viewing the LEDs.
[00103] Once suitably aligned, none of the LEDs 196x may be lit, at which time indications from the speaker 88 might also cease. Enablement or disablement of the speaker 88 though need not coincide with enablement or disablement of the LEDs 196x, and instead use of the speaker may be limited to gross misalignment conditions, for example, when no photodetector 176 in the external charger 170' is receiving a suitable level of intensity Iax. Speaker 88 may also be dispensed with.
[00104] Because the disclosed optical techniques for determining and indicating external charger / IPG alignment do not depend on electrical measurements taken during production of a magnetic field 80, the techniques may be used prior to a charging sessions, i.e., prior to use of the external charger 170 to produce a magnetic charging field 80. This is beneficial, as it allows a patient to set the positioning of the external charger 170 before the charging session begins, which hopefully the patient would not need to revisit later during the charging session. However, should alignment change during the charging session, the disclosed techniques can still notify the user and to suggest corrections, as explained above.
[00105] It should also be noted that the optical alignment techniques described above (Fig. 14A-15D) with respect to the external charger 170 (Fig. 14A-15D) can also be used with the external controllers 150 and 150'. This may be beneficial to ensure good optical coupling, and hence reduced optical attenuation, between the two before or during the communicating data. The disclosed optical alignment techniques may also be used in conjunction with the prior art alignment techniques described earlier. For example, the prior art techniques can be used to enable coarse alignment between the external device and the IPG 110, with the disclosed optical techniques then used for fine alignment assessment and adjustment.
[00106] Figure 16 shows another embodiment of an external charger 170" system that can optically communicate with IPG 1 10. In this example, optical components have been moved out of the external charger 170 (Fig. 12), and into a charging head 250, including the photoemitter 174, the photodetector 176, and if necessary, optical transmitter and receiver circuitry 184 and 186. The charging head also includes the charging coil 76. These components may be integrated on a PCB 256, and contained within a housing 258, which may be significantly smaller and less complicated that the housing 77 used by the external charger 170. As shown, the charging head 250 includes a window assembly 172, similar to that described earlier for external charger 170 but could include the other optical device placement options discussed in Figure 9. The window assembly 172 and optical devices 176 and 174 are preferably centered within the charging coil 76 in the head, which as noted earlier assists with determining alignment between the charging head for the same reasons discussed earlier. Charging head 250 could also include different photodetectors 176x to allow for misalignment position determination, and could include direction indicators 196x (see Figs. 15A-15D), but this is not shown for convenience. [00107] The charging head 250 communicates with a mobile controller such as the external controller 50 (Fig. 2A) or mobile device 200 as discussed earlier (see Fig. 1 1), or an external charger 70 (not shown). As depicted, the charging head 250 includes a cable 252 and a connector 254 that can couple to appropriate ports 58 or 208 on the relevant external device, which can provide a graphical user interface providing functionality similar to the user interface 82 of the external charger 70 (Fig. 4A), as described previously. Power for the charging head 250, as well as to generate the magnetic charging field 80 from the charging coil 76, can come from the external device via cable 252.
[00108] The external charger 170" can otherwise operate similarly with the external chargers 170 and 170' described earlier to optically communicate relevant charging information, and to allow the external device to determine charging head 250 / IPG 1 10 alignment using such optical communications. The graphical user interfaces of the external device are further useful in that they can provide indications of misalignment (either using their speakers, or by displaying information on their graphical user interfaces). If the charging head 250 has multiple photodetectors 176x allowing for misalignment direction assessment (see Figs. 15A-15D), the direction indications concerning how to move the charging head 250 for better alignment can be displayed on the graphical user interfaces of these devices, essentially taking the place of LEDs 196x in Figure 15D.
[00109] The external charger 170" of Figure 11, while having different pieces, may be more convenient for a patient, because, like optical communication head 210 (Fig. 1 1), it allows the charging head 250 to be placed proximate to the IPG 1 10 to allow optical communications and wireless charging to take place, while the external device can remain relatively distant from the IPG 1 10 by virtue of the length of cable 252, making it easier to access.
[00110] The design of IPG 1 10 and external chargers 170, 170' and 170" provided reliable means for optically communicating through the patient's tissue 100, and the same benefits discussed earlier for external controller / IPG communications apply here as well.
[00111] Optical communications between the IPG 110 and the external controller may render certain aspects of the prior art IPG 10 and external controller 50 unnecessary. For example, as FSK communications are not used, FSK modulation and demodulation circuitry (Fig. 3, 41, 43, 61 and 62) as well as telemetry coils 34 and 54 are not necessary, and these coils are thus shown in dotted lines in IPG 1 10 and the various external controllers in recognition of this fact. This is significant, as coils 34 and 54 take up room in their respective, which may now be made smaller when optical communications are employed. Eliminating the telemetry coil 34 from the IPG 110 is particularly beneficial, as space is at a premium in an implantable devices, and because it is always desirable to make such implantable devices smaller to minimize inconvenience to the patient. That being said, FSK communications still could be used between IPG 1 10 and an external controller in addition to the optical communications disclosed herein. As an additional benefit, optical communications will not be subject to or provide electromagnetic interference. This can simplify circuit design in the disclosed IPG and external controllers, as coupling between such circuitry and the coils 34 or 54 is a non-issue.
[00112] Optical communications between the IPG 110 and the external charger may also render certain aspects of the prior art IPG 10 and external charger 70 unnecessary. For example, because the external charger and IPG 1 10 can communicate optically via link 101b, LSK communications from the IPG 1 10 to the external charger may not be necessary, and hence relevant LSK circuitry in both devices are shown in dotted lines (Fig. 14A). That being said, LSK communications still could be used between IPG 1 10 and an external charger in addition to the optical communications disclosed herein.
[00113] Optical communications also allows for the integration of the external controller and the external charger in a single device. For example, Figure 17 shows an integrated external controller / charger 300 in the form of a modified external controller 150 (see Fig. 9). In external device 300, coil 54 (previously used for FSK telemetry) has been replaced by a charging coil 302 used to provide the magnetic charging field 80 to charge the IPG's battery. To assist with alignment determinations, the window assembly 304 and underlying photoemitter 164 and photodetector 166 have been moved to be generally centered with respect to the coil 302. In this example, the external controller / charger 300 is integrated in a unitary housing, i.e., case 59.
[00114] The external device 300 can operate in an IPG communications mode having functionality similar to the external charger to set or adjust the therapy settings the IPG 1 10 provides to the patient, and to receive relevant data from the IPG 1 10. The external device 300 can also operate in a charging mode to produce the magnetic charging field. These modes can operate and use optical communications to beneficial ends as discussed previously. Note that redundancies in the external controller and the external charger can be eliminated in the integrated external device 300. For example, the external device 300 may have only one optical transmitter (e.g., 144; Fig. 10) coupled to photoemitter 164, and one optical receiver (e.g., 146, Fig. 10) coupled to one photodetector 166, which would handle optical communications for all modes of operation. External device 300 may also have additional photodetectors to allow for alignment direction determinations (Figs. 15A-15D), and may position the optical devices differently with respect to the case 59 (Fig. 9).
[00115] Figure 18 shows a modified external device 300' having integrated communication and charging capability, which uses a combined communication / charging head 350. Like the heads 210 and 250 described earlier (Figs. 1 1 and 16), the head 350 is coupled by a cable 352 to a mobile controller. The head 350 is essentially similar to the charging head 250 described earlier and can be modified as explained earlier (additional photodetectors, different placement of the optical devices, etc.), although optical communications related to external controller functionality are also passed between the head 350 and the IPG 110 in addition to optical communications used for charging. Otherwise, the external device 300' can operate as external device 300, providing both communication and charging functionality, with the additional convenience of separating the graphical user interface from aspects of the system that need to be proximate to the IPG 1 10.
[00116] Other modifications to the disclosed devices and techniques are possible. For example, the optical radiation used in optical communications need not have a fixed wavelength, but can comprise radiation with a wider frequency spectrum. Optical communications used in different directions (e.g., link 101a, 101b), can occur at different wavelengths, which may facilitate full duplex communications on these links. More than one set of photoemitters and corresponding photodetectors may be used to respectively transmit and receive optical radiation in a given direction along a communication link, which may operate at different wavelengths. The circuitry disclosed herein can also be modified in any number of ways. For example, instead of programming modules in the various control circuitries of the devices, such modules can exists as discrete circuits outside of their control circuitries.
[00117] While it is preferred to use a single window assembly 1 12 in the IPG 1 10, number of window assemblies 1 12 can be used as well. For example, although not depicted, the IPG 110 could contain two window assemblies 1 12 on its top side, one of which contains a photoemitter 114 and the other which contains a photodetector 116. The external controller or charger could likewise contain two window assemblies, one of which contains a photoemitter and the other which contains a photodetector. This would allow different optical links to be supported in different directions (101a and 101b) through different sets of windows. Providing different numbers of window assemblies 1 12 on the IPG 1 10, or a larger window assembly containing a number of photoemitters or photodetectors, may also be useful in determining and indicating alignment. For example, the alignment procedure described above can essentially be reversed, with the external charger providing pulses from its photoemitter, which intensity is detected at a number of photodetectors in the IPG, with such intensities optically reported to the external charger for alignment interpretation. Different window assemblies 112 operating at different wavelengths that correspond with different window assemblies in the external charger can also be used for alignment.
[00118] Another window assembly placed elsewhere on the IPG, for example on its bottom side facing inwardly of the patient, may also be useful to allow the IPG 1 10 to optically communicate with other implanted devices, such as another IPG 110.
[00119] Use of the window assembly 1 12 on the side of the IPG 1 10's case 12 is preferred, but not necessary in all manners in which optical communications are useful. For example, if optical communications are used to provide visual feedback regarding IPG operations, conditions, or codes to a manufacturer, clinician, or patient as described earlier, positioning of the photoemitter 1 14 that provides such indications is less critical. If used for such purposes, the photoemitter 114 could be placed elsewhere, such as in the header 28 (Fig. 1A), and electrically coupled to the circuitry inside the case via additional feedthrough wires between the case 12 and the header 28. Or the photoemitter 1 14 could be placed inside the case, with radiation optically ported through the feedthrough, using a lens, a fiber optical cable, a window, or other structure. A special optical feedthrough different from that used for the electrodes wires could also be provided. Suitable visual indications can be provided even if the optical radiation in these scenarios will travel through more complicated or optically bulky structures.
[00120] Visual indications are especially useful to display operations, conditions, or codes before implantation, such as during manufacturing, or surgery. Particularly useful is optically providing a visual indication of a "go / no-go" signal to the implanting clinician before the IPG is implanted in the patient. In this regard, the IPG 1 10 can be configured to detect the impedance at each electrode 16 after the electrode lead(s) 18 are connected to the IPG 1 10. If any electrode is not within a proper impedance range (e.g., if an electrode is measured to have an open or short circuit), a "no-go" signal could be visually indicated by a photoemitter placed anywhere on the IPG. The implanting clinician can then attempt to re-secure the leads until a "go" signal is visually indicated, at which point the clinician could then safely implant the IPG. Alternatively, the "no-go" signal might indicate a particular electrode that is not being measured with a suitable impedance.
[00121] Providing optical communication functionality to the external devices (e.g., the external controller and external charger) may also be beneficial as an easier way to communicate with or test such devices, or to allow them to optical communicate with each other or with other external devices.
[00122] The following claims at times recite "a" structure, but this should not be construed as limiting scope to devices that only contain a singular one of such structures.
[00123] Although particular embodiments of the present invention have been shown and described, it should be understood that the above discussion is not intended to limit the present invention to these embodiments. It will be obvious to those skilled in the art that various changes and modifications may be made without departing from the spirit and scope of the present invention. Thus, the present invention is intended to cover alternatives, modifications, and equivalents that may fall within the spirit and scope of the present invention as defined by the claims.

Claims

WHAT IS CLAIMED IS;
1. An implantable medical device for communicating with an external device, comprising:
a case;
a window affixed to a side of the case;
a photodetector within the case configured to optically receive through the window a first series of data bits transmitted from an external device; and a photoemitter within the case configured to optically transmit through the window a second series of data bits to the external device.
2. The implantable medical device of claim 1, wherein the case is metallic.
3. The implantable medical device of claims 1 or 2, further comprising a header affixed to the case.
4. The implantable medical device of any of claims 1 to 3, wherein the window is one or more of flat, a lens, or a glassy material.
5. The implantable medical device of any of claims 1 to 4, wherein the side of the case to which the window is affixed is flat.
6. The implantable medical device of any of claims 1 to 5, wherein the window comprises a portion of a window assembly including a collar.
7. The implantable medical device of claim 6, wherein the window is brazed to the collar in the window assembly, and wherein the collar is welded to the case to affix the window to the side of the case.
8. The implantable medical device of claims 6 or 7, wherein the window assembly is substantially flush with the side of the case.
9. The implantable medical device of any of claims 1 to 8, wherein the photodetector and photoemitter are operable at least at one or more visible wavelengths.
10. A system, comprising:
an implantable medical device, comprising
a first case,
a first window affixed to a side of the first case,
a first photodetector within the first case configured to optically receive through the first window a first series of data bits, a first photoemitter within the first case configured to optically transmit through the first window a second series of data bits; and
an external device, comprising
a second photoemitter configured to optically transmit the first series of data bits, and
a second photodetector configured to optically receive the second series of data bits.
11. The system of claim 10, wherein the first and second photodetectors and the first and second photoemitters are operable at least at one or more visible wavelengths.
12. The system of claims 10 or 1 1, wherein the external device is configured to allow a user to set or adjust therapy the implantable medical device provides via the first series of data bits.
13. The system of any of claims 10 to 12, wherein the external device further comprises a second case, and wherein the second photoemitter and the second photodetector are provided through one or more holes in the second case or are located on an outside of the second case.
14. The system of any of claims 10 to 12, wherein the external device further comprises a second case and a second window affixed to the second case, wherein the second photoemitter is configured to optically transmit the first series of data bits through the second window, and wherein the second photodetector configured to optically receive the second series of data bits through the second window.
15. The system of any of claims 10 to 12, wherein the external device comprises a mobile controller with a graphical user interface and a communication head, wherein the second photoemitter and the second photodetector are located on or in the communication head.
16. The system of any of claims 10 to 15, wherein the external device comprises a charging coil configured to produce a charging field to charge a battery in the implantable medical device, and wherein the second series of data bits are used by the external device to control the charging field.
PCT/US2014/053264 2013-09-13 2014-08-28 Implantable medical device with a window and with means for optical communication with external devices WO2015038352A1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201361877871P 2013-09-13 2013-09-13
US61/877,871 2013-09-13
US14/470,854 2014-08-27
US14/470,854 US20150080982A1 (en) 2013-09-13 2014-08-27 Window in a Case of an Implantable Medical Device to Facilitate Optical Communications With External Devices

Publications (1)

Publication Number Publication Date
WO2015038352A1 true WO2015038352A1 (en) 2015-03-19

Family

ID=51570856

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2014/053264 WO2015038352A1 (en) 2013-09-13 2014-08-28 Implantable medical device with a window and with means for optical communication with external devices

Country Status (2)

Country Link
US (1) US20150080982A1 (en)
WO (1) WO2015038352A1 (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT201700078293A1 (en) * 2017-07-11 2019-01-11 Slux Sagl IMPLANTABLE ELECTROMEDICAL DEVICE INSIDE THE HUMAN BODY AND METHOD OF COMMUNICATION WITH THE SAME
WO2019012423A1 (en) * 2017-07-11 2019-01-17 Slux Sagl Electro medical device implantable within the human body and method of communication with the same
EP3804810A1 (en) * 2019-10-09 2021-04-14 BIOTRONIK SE & Co. KG Implantable medical devices and systems with communication/sensing based on near infrared signals
US11575434B2 (en) 2019-10-16 2023-02-07 Wyss Center For Bio And Neuro Engineering Optical transmission for an implantable system
US11936426B2 (en) 2023-02-03 2024-03-19 Wyss Center For Bio And Neuro Engineering Optical transmission for an implantable system

Families Citing this family (111)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8882662B2 (en) 2012-06-27 2014-11-11 Camplex, Inc. Interface for viewing video from cameras on a surgical visualization system
US9642606B2 (en) 2012-06-27 2017-05-09 Camplex, Inc. Surgical visualization system
WO2014189969A1 (en) 2013-05-21 2014-11-27 Camplex, Inc. Surgical visualization systems
EP3046458B1 (en) 2013-09-20 2020-10-21 Camplex, Inc. Surgical visualization systems
US9707395B2 (en) 2014-01-16 2017-07-18 Boston Scientific Neuromodulation Corporation Circuitry for charging a battery in an implantable medical device in accordance with historical parameters impacting battery capacity
US9446244B2 (en) 2014-01-16 2016-09-20 Boston Scientific Neuromodulation Corporation Determining and forecasting end of life for an implantable medical device having a rechargeable battery
US9958339B2 (en) * 2014-02-07 2018-05-01 Boston Scientific Neuromodulation Corporation Temperature sensing circuitry for an implantable medical device
US10702353B2 (en) 2014-12-05 2020-07-07 Camplex, Inc. Surgical visualizations systems and displays
US11154378B2 (en) 2015-03-25 2021-10-26 Camplex, Inc. Surgical visualization systems and displays
US9867994B2 (en) 2015-06-19 2018-01-16 Boston Scientific Neuromodulation Corporation External powering of implantable medical device dependent on energy of provided therapy
US10939847B2 (en) 2015-10-07 2021-03-09 Verily Life Sciences Llc Radio frequency and optical reader scanning array
US20170100597A1 (en) * 2015-10-12 2017-04-13 Medtronic, Inc. Sealed implantable medical device and method of forming same
EP3383247A4 (en) * 2015-11-25 2019-06-26 Camplex, Inc. Surgical visualization systems and displays
US10576292B2 (en) 2015-11-29 2020-03-03 Boston Scientific Neuromodulation Corporation Skull-mounted deep brain stimulator
US10420950B2 (en) 2015-11-29 2019-09-24 Boston Scientific Neuromodulation Corporation Implantable pulse generator usable during a trial stimulation phase and externally powered by magnetic inductive coupling
US10149979B2 (en) 2016-04-04 2018-12-11 Boston Scientific Neuromodulation Corporation System to estimate the location of a spinal cord physiological midline
US10376702B2 (en) 2016-04-04 2019-08-13 Boston Scientific Neuromodulation Corporation System to estimate the location of a spinal cord physiological midline
US10406368B2 (en) 2016-04-19 2019-09-10 Boston Scientific Neuromodulation Corporation Pulse generator system for promoting desynchronized firing of recruited neural populations
DE102016208065A1 (en) * 2016-05-11 2017-11-16 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Housing component and method for its production
WO2018085659A1 (en) * 2016-11-04 2018-05-11 Galvani Bioelectronics Limited Powering an in vivo device using energy from a radioactive source
US11040209B2 (en) 2017-01-19 2021-06-22 Boston Scienitific Neuromodulation Corporation Radio frequency antenna capacitively coupled to a charging coil in an implantable medical device
EP3585475A4 (en) 2017-02-24 2021-01-06 Nalu Medical, Inc. Apparatus with sequentially implanted stimulators
US10758734B2 (en) 2017-02-28 2020-09-01 Boston Scientific Neuromodulation Corporation Implantable medical device with a silicone housing
US10819713B2 (en) 2017-04-24 2020-10-27 Boston Scientific Neuromodulation Corporation Technique to ensure security for connected implantable medical devices
WO2018208691A1 (en) 2017-05-08 2018-11-15 Camplex, Inc. Variable light source
EP3421083A1 (en) * 2017-06-30 2019-01-02 BIOTRONIK SE & Co. KG Implementation of a medical-electrical device and medical-electrical device
EP4049711B1 (en) 2017-08-11 2023-11-01 Boston Scientific Neuromodulation Corporation Paresthesia-free spinal cord stimulation system
US11844947B2 (en) 2017-08-11 2023-12-19 Boston Scientific Neuromodulation Corporation Spinal cord stimulation occurring using monophasic pulses of alternating polarities and passive charge recovery
US11612751B2 (en) 2017-08-11 2023-03-28 Boston Scientific Neuromodulation Corporation Stimulation configuration variation to control evoked temporal patterns
US11338127B2 (en) 2017-08-11 2022-05-24 Boston Scientific Neuromodulation Corporation Stimulation modes to adapt customized stimulation parameters for use in a spinal cord stimulation system
WO2019055428A1 (en) 2017-09-12 2019-03-21 Boston Scientific Neuromodulation Corporation Techniques for sensing incorrect lead connection to an implantable stimulator device
EP3691744B1 (en) 2017-10-04 2021-07-28 Boston Scientific Neuromodulation Corporation Adjustment of stimulation in a stimulator using detected evoked compound action potentials
US10842989B2 (en) 2017-11-08 2020-11-24 Boston Scientific Neuromodulation Corporation System to improve a spinal cord stimulation model based on a physiological midline location
US10994146B2 (en) * 2017-12-12 2021-05-04 Boston Scientific Neuromodulation Corporation External device with electromagnet for use with an implantable medical device
US10881859B2 (en) 2017-12-13 2021-01-05 Boston Scientific Neuromodulation Corporation Steering of target poles in an electrode array in a pulse generator system
WO2019118247A1 (en) 2017-12-15 2019-06-20 Boston Scientific Neuromodulation Corporation Use of charge imbalanced pulses in an implantable stimulator to effect a pseudo-constant dc current bias
US11173308B2 (en) 2018-03-05 2021-11-16 Boston Scientific Neuromodulation Corporation Virtual target pole adjustment based on nerve root trajectory
US10974042B2 (en) 2018-03-26 2021-04-13 Boston Scientific Neuromodulation Corporation System and methods for heart rate and electrocardiogram extraction from a spinal cord stimulation system
US11040202B2 (en) 2018-03-30 2021-06-22 Boston Scientific Neuromodulation Corporation Circuitry to assist with neural sensing in an implantable stimulator device
US20190329039A1 (en) 2018-04-27 2019-10-31 Boston Scientific Neuromodulation Corporation Anodic Stimulation in an Implantable Stimulator System Using Asymmetric Anodic and Cathodic Stimulation Pulses
WO2019217079A1 (en) 2018-05-09 2019-11-14 Boston Scientific Neuromodulation Corporation Determination and use of a wellness factor in an implantable medical device system using qualitative and quantitative measurements
EP3755426B1 (en) 2018-05-11 2023-08-30 Boston Scientific Neuromodulation Corporation Stimulation waveforms with high-and low-frequency aspects in an implantable stimulator device
US11123568B2 (en) 2018-06-01 2021-09-21 Boston Scientific Neuromodulation Corporation Interleaving stimulation patterns provided by an implantable pulse generator
WO2019236298A1 (en) 2018-06-04 2019-12-12 Boston Scientific Neuromodulation Corporation Logging the execution of sub-programs within a stimulation program for an implantable stimulator device
WO2020005589A1 (en) 2018-06-27 2020-01-02 Boston Scientific Neuromodulation Corporation Stimulation field modelling in an implantable stimulator device
US10918874B2 (en) 2018-06-28 2021-02-16 Medtronic, Inc. Sealed package and method of forming same
US11890480B2 (en) 2018-07-03 2024-02-06 Boston Scientific Neuromodulation Corporation Therapy implemented using different sub-perception neuromodulation types
CA3095467C (en) 2018-07-03 2023-03-14 Boston Scientific Neuromodulation Corporation Spinal cord stimulation system with stimulation modes to adapt customized stimulation parameters
US11559355B2 (en) 2018-07-30 2023-01-24 Boston Scientific Neuromodulation Corporation Augmented and virtual reality for use with neuromodulation therapy
WO2020041013A1 (en) 2018-08-23 2020-02-27 Boston Scientific Neuromodulation Corporation Stimulation using long duration waveform phases in a spinal cord stimulator system
AU2019381283B2 (en) 2018-11-16 2022-05-19 Boston Scientific Neuromodulation Corporation Leads for stimulation and sensing in a stimulator device
CA3128166A1 (en) 2019-02-08 2020-08-13 Boston Scientific Neuromodulation Corporation Tools to assist spinal cord stimulation self-reprogramming
CN113382765B (en) 2019-02-08 2023-12-08 波士顿科学神经调制公司 System for delivering tailored neuromodulation doses
AU2019428019B2 (en) 2019-02-08 2023-03-30 Boston Scientific Neuromodulation Corporation Varying stimulation parameters to prevent tissue habituation in a spinal cord stimulation system
EP3921016A1 (en) 2019-02-08 2021-12-15 Boston Scientific Neuromodulation Corporation Fitting algorithm to determine best stimulation parameter in a spinal cord stimulation system
CA3128164C (en) 2019-02-08 2023-09-26 Boston Scientific Neuromodulation Corporation Spinal cord stimulation occurring using monophasic pulses of alternating polarities and passive charge recovery
CN113365690A (en) 2019-02-08 2021-09-07 波士顿科学神经调制公司 Spinal cord stimulation using anodic and cathodic pulses for spinal recruitment or inhibition
CA3129376A1 (en) 2019-02-08 2020-08-13 Boston Scientific Neuromodulation Corporation Fitting algorithm to determine best stimulation parameter in a spinal cord stimulation system
US11273309B2 (en) 2019-02-08 2022-03-15 Boston Scientific Neuromodulation Corporation Linking and concurrent steering of multiple pole configurations in a spinal cord stimulation system
US11273313B2 (en) 2019-04-18 2022-03-15 Boston Scientific Neuromodulation Corporation Dynamic visualization of neuronal sub population interactions
US20220184399A1 (en) 2019-04-30 2022-06-16 Boston Scientific Neuromodulation Corporation Adjustment of Stimulation in Response to Electrode Array Movement in a Spinal Cord Stimulator System
US11738198B2 (en) 2019-05-10 2023-08-29 The Freestate Of Bavaria Represented By The Julius Maximilians-Universität Würzbrg System to optimize anodic stimulation modes
CN114051424A (en) 2019-07-02 2022-02-15 波士顿科学神经调制公司 Spinal cord stimulation system using neural dose determination optimized sub-perception therapy
AU2020368897B2 (en) 2019-10-18 2023-09-21 Boston Scientific Neuromodulation Corporation Neurostimulation device providing sub-perception stimulation
AU2020369847B2 (en) 2019-10-21 2024-01-11 Boston Scientific Neuromodulation Corporation Assessment and adjustment of time-varying pulse patterns in a spinal cord stimulator system
FR3104448B1 (en) * 2019-12-12 2022-08-26 Commissariat Energie Atomique Illumination device implantable in a living being
EP4041373B1 (en) 2020-01-09 2023-10-11 Boston Scientific Neuromodulation Corporation External controller for controlling sub-perception stimulation
WO2021158310A1 (en) 2020-02-05 2021-08-12 Boston Scientific Neuromodulation Corporation Selection of sensing electrodes in a spinal cord stimulator system using sensed stimulation artifacts
EP4103263A1 (en) 2020-02-14 2022-12-21 Boston Scientific Neuromodulation Corporation Systems and methods for using electrospinogram signals for closed loop control in spinal cord stimulation therapy
US11794016B2 (en) 2020-02-14 2023-10-24 Boston Scientific Neuromodulation Corporation Closed loop control in spinal cord stimulation therapy with non- detectable neural responses
EP4106858A1 (en) 2020-02-21 2022-12-28 Boston Scientific Neuromodulation Corporation Selective stimulation of peripheral nerves
CA3167792A1 (en) 2020-03-06 2021-09-10 Boston Scientific Neuromodulation Corporation Neurostimulation device providing sub-perception stimulation
WO2021194684A1 (en) 2020-03-26 2021-09-30 Boston Scientific Neuromodulation Corporation Graphical user interface for adjusting current magnitude in a stimulator device
EP3930828B1 (en) * 2020-05-04 2022-06-01 Synergia Medical Active implantable stimulating device for on-demand stimulation of a vagus nerve
AU2021324583A1 (en) 2020-08-10 2023-04-06 Boston Scientific Neuromodulation Corporation Electrical stimulation systems based on stimulation-evoked responses
EP4204076A1 (en) * 2020-08-28 2023-07-05 Nalu Medical, Inc. Apparatus for delivering customized stimulation waveforms
WO2022072973A1 (en) 2020-09-30 2022-04-07 Boston Scientific Neuromodulation Corporation Pairing of external communication devices with an implantable medical device via a patient remote controller
CA3197467A1 (en) 2020-09-30 2022-04-07 Boston Scientific Neuromodulation Corporation Adjustment of advertising interval in communications between an implantable medical device and an external device
WO2022072972A1 (en) 2020-09-30 2022-04-07 Boston Scientific Neuromodulation Corporation Programming of pairing and mri modes in an implantable medical device system
CA3197794A1 (en) * 2020-11-10 2022-05-19 Pascal Doguet Active implantable medical device comprising an optical action trigger
US20220266022A1 (en) 2021-02-12 2022-08-25 Boston Scientific Neuromodulation Corporation Neural Feedback Assisted DBS
CN116887883A (en) 2021-02-12 2023-10-13 波士顿科学神经调制公司 Automatic selection of electrodes and stimulation parameters in deep brain stimulation systems employing directional leads
EP4281175A1 (en) 2021-02-24 2023-11-29 Boston Scientific Neuromodulation Corporation Closed loop control in spinal cord stimulation
US11786736B2 (en) 2021-03-18 2023-10-17 Boston Scientific Neuromodulation Corporation Methods and systems for lead movement detection and response in DBS therapy
EP4313274A1 (en) 2021-03-25 2024-02-07 Boston Scientific Neuromodulation Corporation Automatic calibration in an implantable stimulator device having neural sensing capability
WO2022251787A1 (en) 2021-05-26 2022-12-01 Boston Scientific Neuromodulation Corporation Forecasting stimulation adjustments in a stimulator system using time series analysis
US20220387808A1 (en) 2021-06-02 2022-12-08 Boston Scientific Neuromodulation Corporation Precise Targeting in a Spinal Cord Stimulation System
WO2022265620A1 (en) 2021-06-14 2022-12-22 Boston Scientific Neuromodulation Corporation Paresthesia-free spinal cord stimulation occurring at lower frequencies involving perception threshold determinations
WO2022266601A1 (en) 2021-06-17 2022-12-22 Boston Scientific Neuromodulation Corporation Ramping of neural dosing for comprehensive spinal cord stimulation therapy
US20230023842A1 (en) 2021-07-22 2023-01-26 Boston Scientific Neuromodulation Corporation Interpolation Methods for Neural Responses
WO2023028435A1 (en) 2021-08-24 2023-03-02 Boston Scientific Neuromodulation Corporation User interface solutions for providing sub-perception stimulation in an implantable stimulator system
WO2023039361A1 (en) 2021-09-08 2023-03-16 Boston Scientific Neuromodulation Corporation Closed loop stimulation adjustments based on local and surround receptive field stimulation
WO2023049669A1 (en) 2021-09-24 2023-03-30 Boston Scientific Neuromodulation Corporation Using evoked potentials for brain stimulation therapies
US20230102847A1 (en) 2021-09-24 2023-03-30 Boston Scientific Neuromodulation Corporation Calibration of Stimulation Circuitry in an Implantable Stimulator Device Using Sensed Neural Responses to Stimulation
WO2023069848A1 (en) 2021-10-19 2023-04-27 Boston Scientific Neuromodulation Corporation Stimulation targeting and calibration for enhanced surround inhibition recruitment in spinal cord stimulation therapy
US20230138443A1 (en) 2021-10-29 2023-05-04 Boston Scientific Neuromodulation Corporation Stimulation Circuitry in an Implantable Stimulator Device for Providing a Tissue Voltage as Useful During Neural Response Sensing
US20230144885A1 (en) 2021-11-05 2023-05-11 Boston Scientific Neuromodulation Corporation Closed loop stimulation based on response avoidance
US20230173273A1 (en) 2021-12-02 2023-06-08 Boston Scientific Neuromodulation Corporation Circuitry to Assist with Neural Sensing in an Implantable Stimulator Device in the Presence of Stimulation Artifacts
US20230173283A1 (en) 2021-12-02 2023-06-08 Boston Scientific Neuromodulation Corporation Variation of Stimulation Location in an Electrode Array in a Spinal Cord Stimulation System
US20230201597A1 (en) 2021-12-28 2023-06-29 Boston Scientific Neuromodulation Corporation Adaptive Deep Brain Stimulation Based on Neural Signals with Dynamics
WO2023137280A1 (en) 2022-01-14 2023-07-20 Boston Scientific Neuromodulation Corporation Algorithm for adjusting a compliance voltage in a stimulator device having neural sensing capability
WO2023137384A1 (en) 2022-01-17 2023-07-20 Boston Scientific Neuromodulation Corporation System for adaptive neural stimulation
WO2023164700A1 (en) 2022-02-28 2023-08-31 Boston Scientific Neuromodulation Corporation Automated selection of electrodes and stimulation parameters in a deep brain stimulation system using sensed neural potentials
WO2023183838A1 (en) 2022-03-25 2023-09-28 Boston Scientific Neuromodulation Corporation Implantable pulse generator charging alerts
US20230355978A1 (en) 2022-05-09 2023-11-09 Boston Scientific Neuromodulation Corporation Duty Cycling Control of Neural Dose in a Spinal Cord Stimulator System
US20240017067A1 (en) 2022-07-13 2024-01-18 Boston Scientific Neuromodulation Corporation Automating bolus stimulation therapy from learned usage
WO2024026367A1 (en) 2022-07-29 2024-02-01 Boston Scientific Neuromodulation Corporation Spinal cord stimulation guiding using evoked potentials
US20240058610A1 (en) 2022-08-16 2024-02-22 Boston Scientific Neuromodulation Corporation Feature selection and sensing optimization for adaptive neuromodulation therapy
US20240058611A1 (en) 2022-08-17 2024-02-22 Boston Scientific Neuromodulation Corporation Using Stimulation Circuitry to Provide DC Offset Compensation at Inputs to Sense Amp Circuitry in a Stimulator Device
WO2024050257A1 (en) 2022-08-30 2024-03-07 Boston Scientific Neuromodulation Corporation Methods and systems for determining baseline voltages for sensed neural response in an implantable stimulator device system
US20240066298A1 (en) 2022-08-31 2024-02-29 Boston Scientific Neuromodulation Corporation Template Based Artifact Reduction in Neuromodulation Applications

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5387259A (en) * 1992-10-20 1995-02-07 Sun Microsystems, Inc. Optical transdermal linking method for transmitting power and a first data stream while receiving a second data stream
US20090076353A1 (en) * 2007-09-18 2009-03-19 Cardiac Pacemakers, Inc. Implantable electro-optical sensor
US20100137948A1 (en) * 2008-12-03 2010-06-03 Boston Scientific Neuromodulation Corporation External charger with adjustable alignment indicator
US20120330138A1 (en) * 2008-09-15 2012-12-27 Hyde Roderick A Systems configured to locate a photonic device disposed in a living subject, and related apparatuses and methods
US20130103124A1 (en) * 2008-11-05 2013-04-25 Incube Labs, Llc Methods for delivery of optical signals to tissue for the treatment of a disease or condition

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5556421A (en) * 1995-02-22 1996-09-17 Intermedics, Inc. Implantable medical device with enclosed physiological parameter sensors or telemetry link
DE102006035547A1 (en) * 2006-07-27 2008-02-21 Deutsches Zentrum für Luft- und Raumfahrt e.V. Transfer arrangement
US9724784B2 (en) * 2009-03-10 2017-08-08 Medtronic, Inc. Optical feedthrough for medical devices
US20100274323A1 (en) * 2009-04-28 2010-10-28 Pacesetter, Inc. Method and system for power management
US9362774B2 (en) * 2012-01-27 2016-06-07 Medtronic, Inc. Battery charging top-off

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5387259A (en) * 1992-10-20 1995-02-07 Sun Microsystems, Inc. Optical transdermal linking method for transmitting power and a first data stream while receiving a second data stream
US20090076353A1 (en) * 2007-09-18 2009-03-19 Cardiac Pacemakers, Inc. Implantable electro-optical sensor
US20120330138A1 (en) * 2008-09-15 2012-12-27 Hyde Roderick A Systems configured to locate a photonic device disposed in a living subject, and related apparatuses and methods
US20130103124A1 (en) * 2008-11-05 2013-04-25 Incube Labs, Llc Methods for delivery of optical signals to tissue for the treatment of a disease or condition
US20100137948A1 (en) * 2008-12-03 2010-06-03 Boston Scientific Neuromodulation Corporation External charger with adjustable alignment indicator

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT201700078293A1 (en) * 2017-07-11 2019-01-11 Slux Sagl IMPLANTABLE ELECTROMEDICAL DEVICE INSIDE THE HUMAN BODY AND METHOD OF COMMUNICATION WITH THE SAME
WO2019012423A1 (en) * 2017-07-11 2019-01-17 Slux Sagl Electro medical device implantable within the human body and method of communication with the same
EP3804810A1 (en) * 2019-10-09 2021-04-14 BIOTRONIK SE & Co. KG Implantable medical devices and systems with communication/sensing based on near infrared signals
US11116983B2 (en) 2019-10-09 2021-09-14 Biotronik Se & Co. Kg Implantable medical devices and systems with communication/sensing based on near infrared signals
US11575434B2 (en) 2019-10-16 2023-02-07 Wyss Center For Bio And Neuro Engineering Optical transmission for an implantable system
US11936426B2 (en) 2023-02-03 2024-03-19 Wyss Center For Bio And Neuro Engineering Optical transmission for an implantable system

Also Published As

Publication number Publication date
US20150080982A1 (en) 2015-03-19

Similar Documents

Publication Publication Date Title
US9496733B2 (en) Optical communications between an implantable medical device and external charger
US20150080982A1 (en) Window in a Case of an Implantable Medical Device to Facilitate Optical Communications With External Devices
US9339660B2 (en) Implantable medical device with one or more magnetic field sensors to assist with external charger alignment
AU2020200562B2 (en) External charger for an implantable medical device having at least one sense coil concentric with a charging coil for determining position
US10625081B2 (en) External charger for an implantable medical device system having a coil for communication and charging
US9446254B2 (en) Charger alignment in an implantable medical device system employing reflected impedance modulation
CN109328089B (en) External charger for implantable medical devices that determine position using phase angle or multiple parameters determined from at least one sensing coil
AU2017286411B2 (en) External charger for an implantable medical device having alignment and centering capabilities
AU2017286413B2 (en) External charger for an implantable medical device for adjusting charging power based on determined position using at least one sense coil
CA3022731C (en) External charger for an implantable medical device for determining position and optimizing power transmission using resonant frequency as determined from at least one sense coil
AU2016229448A1 (en) Assembly with a coaxial audio connector for charging an implantable medical device

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 14767200

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 14767200

Country of ref document: EP

Kind code of ref document: A1